Gene Symbol,Name,Entrez GeneId,Genome Location,Tier,Tumour Types(Somatic),Tumour Types(Germline),Synonyms
ABI1,abl-interactor 1,10006,10:26746593-26860935,1,AML,,"ABI-1,CCDS7150.1,E3B1,ENSG00000136754.17,NM_005470.3,NP_005461,NP_001334958.1,Q8IZP0,SSH3BP1"
ABL1,v-abl Abelson murine leukemia viral oncogene homolog 1,25,9:130713946-130885683,1,"CML, ALL, T-ALL",,"ABL,CCDS35165.1,ENSG00000097007.17,JTK7,NM_007313.2,NP_009297,P00519,c-ABL,p150"
ABL2,"c-abl oncogene 2, non-receptor tyrosine kinase",27,1:179099327-179229601,1,AML,,"ABLL,ARG,CCDS30947.1,ENSG00000143322.19,NM_007314.3,NP_009298,P42684"
ACKR3,atypical chemokine receptor 3,57007,2:236569641-236582358,1,lipoma,,"CCDS2516.1,CMKOR1,CXCR7,ENSG00000144476.5,GPR159,NM_020311.2,NP_064707,P25106,RDC1"
ACSL3,acyl-CoA synthetase long-chain family member 3,2181,2:222860934-222944639,1,prostate,,"ACS3,CCDS2455.1,ENSG00000123983.13,FACL3,NM_004457.3,NP_004448,NP_001341088.1,NP_001341087.1,O95573,PRO2194"
ACVR1,"activin A receptor, type I",90,2:157736444-157875111,1,DIPG,,"ACVR1A,ACVRLK2,ALK2,CCDS2206.1,ENSG00000115170.13,NM_001347666.1,NP_001096,NP_001334595.1,NP_001334594.1,NP_001334592.1,Q04771,SKR1"
ACVR1B,Activin A Receptor Type 1B,91,12:51951701-51994217,1,pancreatic cancer,,"ACVRLK4,ALK4,ActRIB,CCDS44894.2,ENSG00000135503.12,NM_020328.3,NP_064733,P36896,SKR2"
ACVR2A,activin A receptor type 2A,92,2:147844517-147930824,1,"large intestine carcinoma, stomach carcinoma, pancreatic carcinoma, biliary tract, oesophagus",,"ACTRII,ACVR2,CCDS33301.1,ENSG00000121989.14,NM_001616.4,NP_001607,NP_001265508,P27037"
AFDN,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 (AF6)",4301,6:167827635-167970232,1,AL,,"AF-6,AF6,CCDS78199.1,ENSG00000130396.20,MLLT4,NM_001291964.1,NP_001278893"
AFF1,"AF4/FMR2 family, member 1",4299,4:86935002-87141054,1,AL,,"AF-4,AF4,CCDS54775.1,ENSG00000172493.20,MLLT2,NM_001166693.2,NP_001160165,P51825,PBM1"
AFF3,"AF4/FMR2 family, member 3",3899,2:99551121-100106128,1,"ALL, T-ALL",,"CCDS33258.1,ENSG00000144218.18,LAF4,MLLT2-like,NM_001025108.1,NP_001020279,P51826"
AFF4,"AF4/FMR2 family, member 4",27125,5:132875379-132963634,1,ALL,,"AF5Q31,CCDS4164.1,ENSG00000072364.12,MCEF,NM_014423.3,NP_055238,Q9UHB7"
AKT1,v-akt murine thymoma viral oncogene homolog 1,207,14:104769349-104794124,1,"breast, colorectal, ovarian, NSCLC",,"AKT,CCDS9994.1,ENSG00000142208.15,P31749,PKB,PRKBA,RAC"
AKT2,v-akt murine thymoma viral oncogene homolog 2,208,19:40230317-40285395,1,"ovarian, pancreatic",,"CCDS12552.1,ENSG00000105221.16,NM_001626.5,NP_001617,P31751"
ALK,anaplastic lymphoma kinase (Ki-1),238,2:29192774-29921566,1,"ALCL, NSCLC, neuroblastoma, inflammatory myofibroblastic tumour, Spitzoid tumour",neuroblastoma,"CCDS33172.1,CD246,ENSG00000171094.17,NM_004304.4,NP_004295,Q9UM73"
AMER1,APC membrane recruitment protein 1,139285,X:64185117-64205744,1,Wilms tumour,,"CCDS14377.2,ENSG00000184675.9,FAM123B,FLJ39827,NM_152424.3,NP_689637,Q5JTC6,RP11-403E24.2,WTX"
APC,adenomatous polyposis of the colon gene,324,5:112737888-112846239,1,"colorectal, pancreatic, desmoid, hepatoblastoma, glioma, other CNS","colorectal, pancreatic, desmoid, hepatoblastoma, glioma, other CNS","CCDS4107.1,DP2,DP2.5,DP3,ENSG00000134982.16,NM_001354901.1,NP_000029,NP_001341826.1,NP_001341827.1,NP_001341830.1,NP_001341828.1,NP_001341824.1,P25054,PPP1R46"
APOBEC3B,apolipoprotein B mRNA editing enzyme catalytic subunit 3B,9582,22:38982409-38992784,1,,breast cancer,"CCDS13982.1,ENSG00000179750.15,FLJ21201,NM_004900.4,NP_004891,NP_004891.4,PHRBNL,Q9UH17"
AR,Androgen Receptor,367,X:67544036-67730619,1,prostate,,"AIS,CCDS14387.1,DHTR,ENSG00000169083.16,HUMARA,NM_000044.3,NP_000035,NR3C4,P10275,SBMA,SMAX1"
ARHGAP26,Rho GTPase activating protein 26,23092,5:142770377-143229011,1,"AML, MDS",,"CCDS4277.1,ENSG00000145819.16,GRAF,KIAA0621,OPHN1L,OPHN1L1,Q9UNA1"
ARHGAP35,Rho GTPase activating protein 35,2909,19:46918676-47005077,1,endometrial carcinoma,,"CCDS46127.1,ENSG00000160007.18,GRF-1,GRLF1,KIAA1722,NM_004491.4,NP_004482,P190A,Q9NRY4,p190ARhoGAP,p190RhoGAP"
ARHGEF12,RHO guanine nucleotide exchange factor (GEF) 12 (LARG),23365,11:120337078-120489936,1,AML,,"CCDS41727.1,ENSG00000196914.8,KIAA0382,LARG,NM_015313.2,NP_056128,Q9NZN5"
ARID1A,AT rich interactive domain 1A (SWI-like),8289,1:26696033-26782110,1,"clear cell ovarian carcinoma, RCC, breast",,"B120,BAF250,BAF250a,C10rf4,C1orf4,CCDS285.1,ENSG00000117713.19,NM_006015.4,NP_006006,O14497,P270,SMARCF1"
ARID1B,AT rich interactive domain 1B,57492,6:156777374-157210779,1,"breast, hepatocellular carcinoma, clear cell ovarian carcinoma",,"6A3-5,BAF250b,CCDS55072.1,DAN15,ELD/OSA1,ENSG00000049618.22,KIAA1235,NM_020732.3,NP_065783,Q8NFD5,p250R"
ARID2,AT rich interactive domain 2,196528,12:45729665-45908040,1,hepatocellular carcinoma,,"BAF200,CCDS31783.1,DKFZp686G052,ENSG00000189079.15,FLJ30619,KIAA1557,NM_152641.2,NP_689854,Q68CP9"
ARNT,aryl hydrocarbon receptor nuclear translocator,405,1:150809705-150876768,1,AML,,"CCDS970.1,ENSG00000143437.20,HIF-1beta,NM_001668.3,NP_001659,NP_001337154.1,NP_001337155.1,NP_001337153.1,P27540,bHLHe2"
ASPSCR1,"alveolar soft part sarcoma chromosome region, candidate 1",79058,17:81977550-82017404,1,alveolar soft part sarcoma,,"ASPL,ASPS,CCDS58611.1,ENSG00000169696.15,NM_001251888.1,NP_001238817,Q9BZE9,TUG,UBXD9,UBXN9"
ASXL1,additional sex combs like 1,171023,20:32358330-32439319,1,"MDS, CMML",,"CCDS13201.1,ENSG00000171456.17,KIAA0978,NM_015338.5,NP_056153,Q8IXJ9"
ATF1,activating transcription factor 1,466,12:50764292-50821122,1,"malignant melanoma of soft parts, angiomatoid fibrous histiocytoma",,"CCDS8803.1,ENSG00000123268.8,NM_005171.4,NP_005162,P18846,TREB36"
ATIC,5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase,471,2:215311817-215349763,1,ALCL,,"AICARFT,CCDS2398.1,ENSG00000138363.14,IMPCHASE,NM_004044.6,NP_004035,P31939,PURH"
ATM,ataxia telangiectasia mutated,472,11:108222832-108369099,1,T-PLL,"leukaemia, lymphoma, medulloblastoma, glioma","ATA,ATC,ATD,ATDC,CCDS31669.1,ENSG00000149311.18,NM_000051.3,NP_000042,Q13315,TEL1,TELO1"
ATP1A1,"ATPase, Na+/K+ transporting, alpha 1 polypeptide",476,1:116373867-116404772,1,adrenal aldosterone producing adenoma,,"CCDS53351.1,ENSG00000163399.15,NM_001160233.1,NP_001153705,P05023"
ATP2B3,"ATPase, Ca++ transporting, plasma membrane 3",492,X:153536122-153582929,1,adrenal aldosterone producing adenoma,,"CCDS35440.1,CFAP39,CLA2,ENSG00000067842.17,NM_001001344.2,NP_001001344,PMCA3,Q16720,SCAX1"
ATR,ATR serine/threonine kinase,545,3:142449237-142578826,1,"endometrial, gastric, epithelial ovarian, myeloma",oropharyngeal,"CCDS3124.1,ENSG00000175054.14,FRP1,MEC1,NM_001184.3,NP_001175,Q13535,SCKL,SCKL1"
ATRX,alpha thalassemia/mental retardation syndrome X-linked,546,X:77504878-77786269,1,"pancreatic neuroendocrine tumours, paediatric GBM",,"CCDS14434.1,ENSG00000085224.21,JMS,MRX52,NM_000489.4,NP_000480,P46100,RAD54,XH2,XNP"
AXIN1,axin 1,8312,16:287440-352659,1,"colorectal, endometrial, prostate, hepatocellular carcinoma, hepatoblastoma, sporadic medulloblastoma",,"CCDS10405.1,ENSG00000103126.14,NM_003502.3,NP_003493,O15169,PPP1R49"
AXIN2,axin 2,8313,17:65528563-65561647,1,"colorectal carcinoma, stomach carcinoma, hepatocellular carcinoma",colorectal carcinoma,"CCDS11662.1,DKFZp781B0869,ENSG00000168646.12,MGC126582,NM_004655.3,NP_004646,Q9Y2T1"
B2M,beta-2-microglobulin,567,15:44711477-44718877,1,"DLBCL, melanoma, colorectal adenocarcinoma",,"CCDS10113.1,ENSG00000166710.17,NM_004048.2,NP_004039,P61769"
BAP1,BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase),8314,3:52401013-52410350,1,"uveal melanoma, breast, NSCLC, RCC","mesothelioma, skin and uveal melanoma, kidney cancer","CCDS2853.1,ENSG00000163930.9,KIAA0272,NM_004656.3,NP_004647,Q92560,UCHL2,hucep-6"
BARD1,BRCA1 associated RING domain 1,580,2:214725646-214809704,1,breast cancer,"ovarian cancer, breast cancer, endometrioid cancer","CCDS2397.1,ENSG00000138376.10,NM_000465.3,NP_000456,Q99728"
BAX,"BCL2 associated X, apoptosis regulator",581,19:48954929-48961798,1,colorectal cancer,,"BCL2L4,CCDS12744.1,ENSG00000087088.19,NM_004324.3,NP_004315,Q07812"
BCL10,B-cell CLL/lymphoma 10,8915,1:85266248-85277090,1,MALT,,"CARMEN,CCDS704.1,CIPER,CLAP,ENSG00000142867.12,NM_003921.4,NP_003912,NP_001307644.1,O95999,c-E10,mE10"
BCL11A,B-cell CLL/lymphoma 11A,53335,2:60457192-60555154,1,B-CLL,,"BCL11A-L,BCL11A-S,BCL11A-XL,CCDS1862.1,CTIP1,ENSG00000119866.21,EVI9,HBFQTL5,NM_022893.3,NP_075044,ZNF856"
BCL11B,B-cell CLL/lymphoma 11B  (CTIP2),64919,14:99169287-99271228,1,T-ALL,,"CCDS9950.1,CTIP-2,CTIP2,ENSG00000127152.17,NM_138576.3,NP_612808,NP_001269166.1,Q9C0K0,ZNF856B,hRIT1-alpha"
BCL2,B-cell CLL/lymphoma 2,596,18:63123346-63320128,1,"NHL, CLL",,"Bcl-2,CCDS11981.1,ENSG00000171791.12,NM_000633.2,NP_000624,P10415,PPP1R50"
BCL3,B-cell CLL/lymphoma 3,602,19:44748547-44760044,1,CLL,,"BCL4,CCDS12642.2,D19S37,ENSG00000069399.14,NM_005178.4,NP_005169,P20749"
BCL6,B-cell CLL/lymphoma 6,604,3:187721377-187745727,1,"NHL, CLL",,"BCL5,BCL6A,CCDS3289.1,ENSG00000113916.17,LAZ3,NM_001706.4,NP_001697,P41182,ZBTB27,ZNF51"
BCL7A,B-cell CLL/lymphoma 7A,605,12:122019422-122062044,1,BNHL,,"BCL7,CCDS9226.1,ENSG00000110987.8,NM_020993.4,NP_066273,Q4VC05"
BCL9,B-cell CLL/lymphoma 9,607,1:147541412-147626216,1,B-ALL,,"CCDS30833.1,ENSG00000116128.10,NM_004326.3,NP_004317,O00512"
BCL9L,B-cell CLL/lymphoma 9-like,283149,11:118893875-118910904,1,"colorectal cancer, endometrial carcinoma, gastric cancer",,"CCDS8403.1,DLNB11,ENSG00000186174.12,NM_182557.2,NP_872363,Q86UU0"
BCOR,BCL6 corepressor,54880,X:40051248-40097403,1,"retinoblastoma, AML, APL (translocation)",,"CCDS48093.1,ENSG00000183337.16,FLJ20285,KIAA1575,NM_001123385.1,NP_001116857,Q6W2J9"
BCORL1,BCL6 corepressor-like 1,63035,X:130005188-130058083,1,"AML, HNSCC",,"CCDS14616.1,CXorf10,ENSG00000085185.15,FLJ11362,NM_021946.4,NP_068765,NP_001171701.1,Q5H9F3"
BCR,breakpoint cluster region,613,22:23180210-23318037,1,"CML, ALL, AML",,"ALL,BCR1,CCDS13806.1,CML,D22S11,D22S662,ENSG00000186716.20,NM_004327.3,NP_004318,P11274,PHL"
BIRC3,baculoviral IAP repeat-containing 3,330,11:102317495-102337734,1,"CLL, MALT, MCL, MM",,"API2,CCDS8315.1,ENSG00000023445.13,MALT2,MIHC,Q13489,RNF49,c-IAP2,cIAP2,hiap-1"
BLM,Bloom Syndrome,641,15:90717327-90816165,1,,"leukaemia, lymphoma, skin squamous cell, other tumour types","BS,CCDS10363.1,ENSG00000197299.10,NM_001287248.1,NP_001274175,NP_000048,NP_001274177.1,P54132,RECQ2,RECQL3"
BMPR1A,"bone morphogenetic protein receptor, type IA",657,10:86756650-86932838,1,,gastrointestinal polyps,"ACVRLK3,ALK3,CCDS7378.1,CD292,ENSG00000107779.13,NM_004329.2,NP_004320,P36894"
BRAF,v-raf murine sarcoma viral oncogene homolog B1,673,7:140730665-140924928,1,"melanoma, colorectal, papillary thyroid, borderline ovarian, NSCLC, cholangiocarcinoma, pilocytic astrocytoma, Spitzoid tumour, pancreas acinar carcinoma, melanocytic nevus, prostate, gastric",,"BRAF1,CCDS5863.1,ENSG00000157764.13,NM_004333.4,NP_004324"
BRCA1,familial breast/ovarian cancer gene 1,672,17:43044295-43125483,1,ovarian,"breast, ovarian","BRCC1,CCDS11456.2,ENSG00000012048.21,FANCS,NM_007300.3,NP_009231,P38398,PPP1R53,RNF53"
BRCA2,familial breast/ovarian cancer gene 2,675,13:32315474-32400266,1,"breast, ovarian, pancreatic","breast, ovarian, pancreatic, leukaemia  (FANCB, FANCD1)","BRCC2,CCDS9344.1,ENSG00000139618.14,FACD,FAD,FAD1,FANCD,FANCD1,P51587,XRCC11"
BRD3,bromodomain containing 3,8019,9:134030305-134068017,1,lethal midline carcinoma of young people,,"CCDS6980.1,ENSG00000169925.16,KIAA0043,NM_007371.3,NP_031397,ORFX,Q15059,RING3L"
BRD4,bromodomain containing 4,23476,19:15235519-15280451,1,lethal midline carcinoma of young people,,"CAP,CCDS12328.1,ENSG00000141867.17,HUNK1,HUNKI,MCAP,NM_058243.2,NP_490597,O60885"
BRIP1,BRCA1 interacting protein C-terminal helicase 1,83990,17:61681266-61863521,1,,"AML, leukaemia, breast","BACH1,CCDS11631.1,ENSG00000136492.8,FANCJ,NM_032043.2,NP_114432,OF,Q9BX63"
BTG1,"B-cell translocation gene 1, anti-proliferative",694,12:92140278-92145897,1,B-CLL,,"APRO2,CCDS9043.1,ENSG00000133639.4,NM_001731.2,NP_001722,P62324"
BTK,Bruton agammaglobulinemia tyrosine kinase,695,X:101349447-101390796,1,"CLL, mantle cell lymphoma, WM",,"AGMX1,ATK,CCDS76003.1,ENSG00000010671.15,IMD1,NM_001287344.1,NP_001274273,PSCTK1,Q06187,XLA"
BUB1B,BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast),701,15:40161026-40221136,1,,rhabdomyosarcoma,"BUBR1,Bub1A,CCDS10053.1,ENSG00000156970.12,MAD3L,NM_001211.5,NP_001202,NP_001202.4,O60566,SSK1"
CACNA1D,"calcium channel, voltage-dependent, L type, alpha 1D subunit",776,3:53495049-53813733,1,adrenal aldosterone producing adenoma,,"CACH3,CACN4,CACNL1A2,CCDS2872.1,CCHL1A2,Cav1.3,ENSG00000157388.16,Q01668"
CALR,calreticulin,811,19:12938607-12944489,1,"MPN, MDS",,"CCDS12288.1,CRT,ENSG00000179218.13,FLJ26680,NM_004343.3,NP_004334,P27797,RO,SSA,cC1qR"
CAMTA1,calmodulin binding transcription activator 1,23261,1:6785324-7769706,1,epithelioid haemangioendothelioma,,"CCDS30576.1,ENSG00000171735.18,KIAA0833,NM_015215.3,NP_056030,NP_001336537.1,Q9Y6Y1"
CANT1,calcium activated nucleotidase 1,124583,17:78991717-79009817,1,prostate,,"CCDS11760.1,ENSG00000171302.16,NM_138793.3,NP_001153245,NP_620148,Q8WVQ1,SCAN-1,SHAPY"
CARD11,"caspase recruitment domain family, member 11",84433,7:2906141-3043945,1,DLBCL,,"BIMP3,CARMA1,CCDS5336.2,ENSG00000198286.9,NM_032415.5,NP_001311210,NP_115791,Q9BXL7"
CARS,cysteinyl-tRNA synthetase,833,11:3000922-3057437,1,ALCL,,"CARS1,CCDS41600.1,ENSG00000110619.17,NM_001194997.1,NP_001014437,NP_001181926.1,P49589"
CASP8,"caspase 8, apoptosis-related cysteine peptidase",841,2:201258036-201287711,1,"hepatocellular, oral squamous cell, breast",,"CCDS42798.1,Casp-8,ENSG00000064012.21,FLICE,MACH,MCH5,NM_001080125.1,NP_001073594,Q14790"
CBFA2T3,"core-binding factor, runt domain, alpha subunit 2; translocated to, 3 (MTG-16)",863,16:88874858-88977204,1,AML,,"CCDS10972.1,ENSG00000129993.14,ETO2,MTG16,MTGR2,NM_005187.5,NP_005178,O75081,RUNX1T3,ZMYND4"
CBFB,"core-binding factor, beta subunit",865,16:67029245-67101022,1,AML,,"CCDS45508.1,ENSG00000067955.13,NM_022845.2,NP_074036,PEBP2B,Q13951"
CBL,Cas-Br-M (murine) ecotropic retroviral transforming,867,11:119206276-119308149,1,"AML, JMML, MDS",,"CBL2,CCDS8418.1,ENSG00000110395.6,NM_005188.3,NP_005179,P22681,RNF55,c-Cbl"
CBLB,Cas-Br-M (murine) ecotropic retroviral transforming sequence b,868,3:105655461-105869043,1,AML,,"CCDS2948.1,Cbl-b,ENSG00000114423.19,NM_170662.4,NP_001308717,NP_733762,NP_001308745.1,NP_001308736.1,NP_001308723.1,NP_001308749.1,NP_001308720.1,NP_001308740.1,NP_001308728.1,NP_001308727.1,NP_001308735.1,NP_001308726.1,NP_001308722.1,NP_001308724.1,NP_001308751.1,NP_001308725.1,NP_001308737.1,Q13191,RNF56"
CBLC,Cas-Br-M (murine) ecotropic retroviral transforming sequence c,23624,19:44777869-44800634,1,AML,,"CBL-3,CBL-SL,CCDS12643.1,ENSG00000142273.11,NM_012116.3,NP_036248,Q9ULV8,RNF57"
CCDC6,coiled-coil domain containing 6,8030,10:59788763-59906656,1,"papillary thyroid, CML, NSCLC",,"CCDS7257.1,D10S170,ENSG00000108091.10,H4,NM_005436.4,NP_005427,PTC,Q16204,TPC,TST1"
CCNB1IP1,"cyclin B1 interacting protein 1, E3 ubiquitin protein ligase",57820,14:20311368-20333312,1,leiomyoma,,"C14orf18,CCDS9547.1,ENSG00000100814.17,HEI10,NM_182852.3,NP_878272,Q9NPC3"
CCND1,cyclin D1,595,11:69641087-69654474,1,"CLL, B-ALL, breast",,"BCL1,CCDS8191.1,D11S287E,ENSG00000110092.3,NM_053056.2,NP_444284,P24385,PRAD1,U21B31"
CCND2,cyclin D2,894,12:4273772-4305350,1,"NHL,CLL",,"CCDS8524.1,ENSG00000118971.7,NM_001759.3,NP_001750,P30279"
CCND3,cyclin D3,896,6:41934933-41941848,1,MM,,"CCDS4863.1,ENSG00000112576.12,NM_001760.4,NP_001751,P30281"
CCNE1,cyclin E1,898,19:29811898-29824308,1,serous ovarian,,"CCDS12419.1,CCNE,ENSG00000105173.13,NM_001322261.1,NP_001229,NP_001309190.1,NP_001309188.1,P24864"
CD274,CD274 molecule,29126,9:5450525-5470547,1,"PMBL, Hodgkin lymphoma",,"B7-H,B7-H1,B7H1,CCDS6464.1,ENSG00000120217.13,NM_014143.3,NP_054862,PD-L1,PDCD1LG1,PDL1,Q9NZQ7"
CD74,"CD74 molecule, major histocompatibility complex, class II invariant chain",972,5:150402152-150412751,1,NSCLC,,"CCDS47309.1,DHLAG,ENSG00000019582.14,NM_001025159.2,NP_001020330,P04233"
CD79A,"CD79a molecule, immunoglobulin-associated alpha",973,19:41877120-41881372,1,"DLBCL, WM",,"CCDS12589.1,ENSG00000105369.9,IGA,MB-1,NM_001783.3,NP_001774,P11912"
CD79B,"CD79b molecule, immunoglobulin-associated beta",974,17:63928740-63932336,1,"DLBCL, WM",,"B29,CCDS42372.1,ENSG00000007312.12,IGB,NM_001039933.1,NP_001035022,P40259"
CDC73,cell division cycle 73,79577,1:193122017-193253901,1,parathyroid adenoma,"parathyroid adenoma, multiple ossifying jaw fibroma","C1orf28,CCDS1382.1,ENSG00000134371.11,FIHP,HRPT1,HRPT2,NM_024529.4,NP_078805,Q6P1J9,parafibromin"
CDH1,"cadherin 1, type 1, E-cadherin (epithelial) (ECAD)",999,16:68737225-68835548,1,"lobular breast, gastric",gastric,"CCDS10869.1,CD324,ENSG00000039068.18,NM_004360.4,NP_004351,P12830,UVO,uvomorulin"
CDH11,"cadherin 11, type 2, OB-cadherin (osteoblast)",1009,16:64943753-65122198,1,aneurysmal bone cyst,,"CAD11,CCDS10803.1,ENSG00000140937.13,NM_001797.3,NP_001788,OB,P55287"
CDK12,cyclin-dependent kinase 12,51755,17:39462039-39535146,1,serous ovarian,,"CCDS11337.1,CRK7,CRKR,CRKRS,ENSG00000167258.13,KIAA0904,NM_016507.3,NP_057591,Q9NYV4"
CDK4,cyclin-dependent kinase 4,1019,12:57747727-57752521,1,,melanoma,"CCDS8953.1,ENSG00000135446.16,NM_000075.3,NP_000066,P11802,PSK-J3"
CDK6,cyclin-dependent kinase 6,1021,7:92604921-92833917,1,ALL,,"CCDS5628.1,ENSG00000105810.9,NM_001259.6,NP_001250,PLSTIRE,Q00534"
CDKN1B,"cyclin-dependent kinase inhibitor 1B (p27, Kip1)",1027,12:12717124-12722371,1,"breast, small intestine neuroendocrine tumours","pituitary, parathyroid","CCDS8653.1,ENSG00000111276.10,KIP1,NM_004064.4,NP_004055,P27KIP1,P46527"
CDKN2A,cyclin-dependent kinase inhibitor 2A (p16(INK4a)) gene,1029,9:21968056-21974866,1,"melanoma, multiple other tumour types","melanoma, pancreatic","ARF,CCDS56565.1,CDK4I,CDKN2,CMM2,ENSG00000147889.17,INK4,INK4a,MLM,MTS1,NP_001182061.1,P42771,p14,p14ARF,p16,p16INK4a,p19,p19Arf"
CDKN2C,"cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)",1031,1:50960745-50974633,1,"glioma, MM",,"CCDS555.1,ENSG00000123080.10,INK4C,P42773,p18"
CDX2,caudal type homeo box transcription factor 2,1045,13:27962137-27971139,1,AML,,"CCDS9328.1,CDX3,ENSG00000165556.9,NM_001265.4,NP_001256,NP_001256.3,Q99626"
CEBPA,"CCAAT/enhancer binding protein (C/EBP), alpha",1050,19:33299934-33302564,1,"AML, MDS",,"C/EBP-alpha,CCDS54243.1,CEBP,ENSG00000245848.2,NM_004364.4,NP_004355,NP_001272758.1,NP_001274364.1,NP_001274353.1,P49715"
CHCHD7,coiled-coil-helix-coiled-coil-helix domain containing 7,79145,8:56211756-56218615,1,salivary adenoma,,"CCDS34895.1,COX23,ENSG00000170791.17,MGC2217,NM_001011668.2,NP_001011668,Q9BUK0"
CHD4,chromodomain helicase DNA binding protein 4,1108,12:6570088-6607476,1,uterine serous carcinoma,,"CCDS8552.1,ENSG00000111642.15,Mi-2b,Mi2-BETA,NM_001273.3,NP_001264"
CHEK2,CHK2 checkpoint homolog (S. pombe),11200,22:28687763-28741838,1,,breast,"CCDS33629.1,CDS1,CHK2,ENSG00000183765.20,HuCds1,NM_001005735.1,NP_001005735,O96017,PP1425,RAD53,bA444G7"
CIC,capicua homolog,23152,19:42284665-42295797,1,"oligodendroglioma, soft tissue sarcoma",,"CCDS12601.1,ENSG00000079432.7,KIAA0306,NM_015125.4,NP_055940,Q96RK0"
CIITA,"class II, major histocompatibility complex, transactivator",4261,16:10877198-10924983,1,"PMBL, Hodgkin lymphoma",,"C2TA,CCDS73826.1,ENSG00000179583.19,MHC2TA,NLRA,NM_001286402.1,NP_001273331"
CLIP1,CAP-GLY domain containing linker protein 1,6249,12:122271434-122422569,1,Spitzoid tumour,,"CCDS58285.1,CLIP,CLIP-170,CLIP170,CYLN1,ENSG00000130779.19,NM_001247997.1,NP_001234926,P30622,RSN"
CLTC,"clathrin, heavy polypeptide (Hc)",1213,17:59619689-59696956,1,"ALCL, renal",,"CCDS74115.1,CLTCL2,ENSG00000141367.11,Hc,NM_001288653.1,NP_001275582"
CLTCL1,"clathrin, heavy polypeptide-like 1",8218,22:19179473-19291714,1,ALCL,,"CCDS46662.2,CHC22,CLH22,CLTCL,CLTD,ENSG00000070371.15,NM_007098.3,NP_009029,P53675"
CNBP,"CCHC-type zinc finger, nucleic acid binding protein",7555,3:129170102-129183910,1,aneurysmal bone cyst,,"CCDS46906.1,CNBP1,DM2,ENSG00000169714.16,NM_001127192.1,NP_001120664,P62633,RNF163,ZCCHC22,ZNF9"
CNOT3,CCR4-NOT transcription complex subunit 3,4849,19:54141396-54155680,1,T-ALL,,"CCDS12880.1,ENSG00000088038.18,KIAA0691,LENG2,NOT3,NOT3H,O75175"
CNTRL,centriolin,11064,9:121075012-121177608,1,"MPN, NHL",,"CCDS35118.1,CEP1,CEP110,ENSG00000119397.16,Q7Z7A1"
COL1A1,"collagen, type I, alpha 1",1277,17:50183289-50201632,1,"DFSP, aneurysmal bone cyst",,"CCDS11561.1,ENSG00000108821.13,NP_000079.2,OI4,P02452"
COL2A1,"collagen, type II, alpha 1",1280,12:47972965-48004486,1,"chondrosarcoma, enchondroma",,"AOM,CCDS41778.1,ENSG00000139219.18,NM_001844.4,NP_001835,P02458,SEDC,STL1"
CREB1,cAMP responsive element binding protein 1,1385,2:207529892-207603431,1,"clear cell sarcoma, angiomatoid fibrous histiocytoma",,"CCDS2375.1,ENSG00000118260.14,NM_134442.4,NP_604391,P16220"
CREB3L1,cAMP responsive element binding protein 3-like 1,90993,11:46277661-46321422,1,myxofibrosarcoma,,"CCDS53620.1,ENSG00000157613.10,NM_052854.3,NP_443086,OASIS,Q96BA8"
CREB3L2,cAMP responsive element binding protein 3-like 2,64764,7:137874979-138002057,1,fibromyxoid sarcoma,,"BBF2H7,CCDS34760.1,ENSG00000182158.14,NM_194071.3,NP_919047,NP_001305175.1,Q70SY1,TCAG_1951439"
CREBBP,CREB binding protein (CBP),1387,16:3725054-3880726,1,"ALL, AML, DLBCL, B-NHL",,"CBP,CCDS10509.1,ENSG00000005339.14,KAT3A,NM_004380.2,NP_004371,Q92793,RSTS,RTS"
CRLF2,cytokine receptor-like factor 2,64109,X:1190490-1212750,1,"B-ALL, Downs associated ALL",,"CCDS75945.1,CRL2,ENSG00000205755.11,NM_022148.3,NP_071431,Q9HC73,TSLPR"
CRTC1,CREB regulated transcription coactivator 1,23373,19:18683678-18782333,1,salivary gland mucoepidermoid,,"CCDS42525.1,ENSG00000105662.15,FLJ14027,KIAA0616,MECT1,NM_001098482.1,NP_001091952,Q6UUV9,TORC1"
CRTC3,CREB regulated transcription coactivator 3,64784,15:90530068-90642813,1,salivary gland mucoepidermoid,,"CCDS32331.1,ENSG00000140577.15,FLJ21868,NM_022769.4,NP_073606,Q6UUV7"
CSF3R,colony stimulating factor 3 receptor (granulocyte),1441,1:36466043-36483278,1,"aCML, CNL,  leukaemia lymphoma and MDS associated with severe congenital neutropenia, CMML, de novo AML, MDS",,"CCDS414.1,CD114,ENSG00000119535.17,GCSFR,NM_156039.3,NP_724781,Q99062"
CTCF,CCCTC-binding factor,10664,16:67562467-67639176,1,"endometrial, breast, head and neck cancer",,"CCDS10841.1,ENSG00000102974.15"
CTNNB1,"catenin (cadherin-associated protein), beta 1",1499,3:41220551-41239888,1,"colorectal, ovarian,  hepatoblastoma, pleomorphic salivary gland adenoma, other tumour types",,"CCDS2694.1,CTNNB,ENSG00000168036.17,armadillo,beta-catenin"
CUX1,cut-like homeobox 1,1523,7:101816011-102258233,1,"endometrial, melanoma, colorectal, AML, MDS, other tumour types",,"CASP,CCDS56498.1,CDP,CDP/Cut,CDP/Cux,CDP1,CUT,CUTL1,CUX,Clox,Cux/CDP,ENSG00000257923.10,GOLIM6,NM_001202543.1,NP_001189472,P39880"
CXCR4,C-X-C motif chemokine receptor 4,7852,2:136114349-136116243,1,WM,,"CCDS33295.1,CD184,D2S201E,ENSG00000121966.6,HM89,HSY3RR,LESTR,NM_001008540.1,NPY3R,NPYR,NPYY3R,NP_001008540,P61073,fusin"
CYLD,familial cylindromatosis gene,1540,16:50742760-50801935,1,cylindroma,cylindroma,"CCDS45482.1,CYLD1,ENSG00000083799.17,KIAA0849,Q9NQC7,USPL2"
DAXX,death-domain associated protein,1616,6:33318558-33323014,1,"pancreatic neuroendocrine tumour, paediatric glioblastoma",,"CCDS4776.1,DAP6,ENSG00000204209.12,NM_001350.4,NP_001341,NP_001135441,NP_001135442.1,Q9UER7"
DCTN1,dynactin 1,1639,2:74361154-74380355,1,"inflammatory myofibroblastic tumour, Spitzoid tumour",,"CCDS1939.1,ENSG00000204843.12,NM_004082.4,NP_004073,Q14203"
DDB2,damage-specific DNA binding protein 2,1643,11:47214942-47239240,1,,"skin basal cell, skin squamous cell, melanoma","CCDS7927.1,DDBB,ENSG00000134574.11,FLJ34321,NM_000107.2,NP_000098,Q92466,UV-DDB2,XPE"
DDIT3,DNA-damage-inducible transcript 3,1649,12:57516589-57520517,1,liposarcoma,,"CCDS55838.1,CHOP,CHOP10,ENSG00000175197.12,GADD153,NM_001195056.1,NP_001181985,NP_001181983,NP_001181982,NP_001181984,P35638"
DDR2,discoidin domain receptor 2,4921,1:162632465-162787400,1,"squamous cell carcinoma, NSCLC",,"CCDS1241.1,ENSG00000162733.16,NM_001014796.1,NP_001014796,NP_001341912.1,NP_001341911.1,NTRKR3,Q16832,TKT,TYRO10"
DDX10,DEAD (Asp-Glu-Ala-Asp) box polypeptide 10,1662,11:108665025-108940930,1,AML*,,"CCDS8342.1,Dbp4,ENSG00000178105.9,HRH-J8,NM_004398.3,NP_004389,Q13206"
DDX3X,"DEAD-box helicase 3, X-linked",1654,X:41333284-41351668,1,"CLL, medulloblastoma",,"CCDS43931.1,DBX,DDX14,DDX3,ENSG00000215301.10,HLP2,NM_001356.4,NP_001347"
DDX5,DEAD (Asp-Glu-Ala-Asp) box polypeptide 5,1655,17:64499616-64506521,1,prostate,,"CCDS11659.1,ENSG00000108654.14,G17P1,HLR1,NM_004396.4,NP_001307525,NP_004387,NP_001307524,P17844,p68"
DDX6,DEAD (Asp-Glu-Ala-Asp) box polypeptide 6,1656,11:118747766-118790948,1,B-NHL,,"CCDS44751.1,ENSG00000110367.11,HLR2,NM_001257191.2,NP_001244120,P26196,RCK"
DEK,DEK oncogene (DNA binding),7913,6:18223868-18264823,1,AML,,"CCDS34344.1,D6S231E,ENSG00000124795.14,NM_003472.3,NP_003463,P35659"
DICER1,"dicer 1, ribonuclease type III",23405,14:95086228-95158010,1,"sex cord-stromal tumour, TGCT, embryonal rhabdomyosarcoma, pleuropulmonary blastoma, pituitary blastoma, Wilms tumour, thyroid cancer, other tumour types",pleuropulmonary blastoma,"CCDS9931.1,Dicer,ENSG00000100697.14,HERNA,K12H4.8-LIKE,KIAA0928,MNG1,NM_030621.4,NP_001278557,NP_085124,Q9UPY3"
DNAJB1,DnaJ heat shock protein family (Hsp40) member B1,3337,19:14514770-14518420,1,fibrolamellar hepatocellular carcinoma,,"CCDS12312.1,ENSG00000132002.7,HSPF1,Hsp40,NM_006145.2,NP_006136,P25685,RSPH16B,Sis1"
DNM2,dynamin 2,1785,19:10718131-10831903,1,T-ALL,,"CCDS45969.1,CMT2M,CMTDI1,CMTDIB,DI-CMTB,DYN2,DYNII,ENSG00000079805.16,NM_001005361.2,NP_001005361,P50570"
DNMT3A,DNA (cytosine-5-)-methyltransferase 3 alpha,1788,2:25227855-25342590,1,AML,,"CCDS33157.1,ENSG00000119772.16,NM_175629.2,NP_783328,Q9Y6K1"
DROSHA,drosha ribonuclease III,29102,5:31400497-31532061,1,"Wilms tumour, NSCLC, bladder carcinoma",,"CCDS47195.1,ENSG00000113360.16,Etohi2,HSA242976,NM_013235.4,NP_037367,Q9NRR4,RN3,RNASE3L,RNASEN"
EBF1,early B-cell factor 1,1879,5:158695920-159099761,1,lipoma,,"CCDS4343.1,COE1,EBF,ENSG00000164330.16,NM_024007.4,NP_076870,NP_001277289.1,NP_001311037.1,NP_001311036.1,NP_001311040.1,NP_001311035.1,NP_001311032.1,NP_001311030.1,OLF1,Q9UH73"
EGFR,"epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)",1956,7:55019101-55211628,1,"glioma, NSCLC",NSCLC,"CCDS5514.1,ENSG00000146648.17,ERBB,ERBB1,NM_005228.3,NP_005219,P00533"
EIF3E,"eukaryotic translation initiation factor 3, subunit E",3646,8:108201743-108248765,1,colorectal,,"CCDS6308.1,EIF3S6,ENSG00000104408.9,INT6,NM_001568.2,NP_001559,P60228,eIF3-p48,eIF3e"
EIF4A2,"eukaryotic translation initiation factor 4A, isoform 2",1974,3:186783547-186789900,1,NHL,,"BM-010,CCDS3282.1,DDX2B,EIF4A,EIF4F,ENSG00000156976.16,NM_001967.3,NP_001958,Q14240"
ELF4,E74-like factor 4 (ets domain transcription factor),2000,X:130064928-130110495,1,AML,,"CCDS14617.1,ELFR,ENSG00000102034.16,MEF,NM_001421.3,NP_001412,Q99607"
ELK4,"ELK4, ETS-domain protein (SRF accessory protein 1)",2005,1:205607943-205631962,1,prostate,,"CCDS1456.1,ENSG00000158711.13,NM_001973.3,NP_001964,P28324,SAP1"
ELL,ELL gene (11-19 lysine-rich leukemia gene),8178,19:18442663-18522127,1,AL,,"C19orf17,CCDS12380.1,ELL1,ENSG00000105656.12,Men,NM_006532.3,NP_006523,P55199,PPP1R68"
EML4,echinoderm microtubule associated protein like 4,27436,2:42169350-42332548,1,NSCLC,,"C2orf2,CCDS1807.1,ELP120,ENSG00000143924.18,NM_019063.4,NP_061936,NP_061936.2,Q9HC35,ROPP120"
EP300,300 kd E1A-Binding protein gene,2033,22:41091786-41180079,1,"colorectal, breast, pancreatic, AML, ALL, DLBCL",,"CCDS14010.1,ENSG00000100393.12,KAT3B,NM_001429.3,NP_001420,Q09472,p300"
EPAS1,endothelial PAS domain protein 1,2034,2:46297402-46386703,1,"paraganglioma, pheochromocytoma, central nervous system hemangioblastomas",,"CCDS1825.1,ENSG00000116016.13,HIF2A,HLF,MOP2,NM_001430.4,NP_001421,PASD2,Q99814,bHLHe73"
EPS15,epidermal growth factor receptor pathway substrate 15 (AF1p),2060,1:51354263-51519328,1,ALL,,"AF-1P,CCDS557.1,ENSG00000085832.16,MLLT5,NM_001981.2,NP_001972,P42566"
ERBB2,"v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)",2064,17:39700080-39728662,1,"breast, ovarian, other tumour types, NSCLC, gastric",,"CCDS32642.1,CD340,ENSG00000141736.13,HER-2,HER2,NEU,NGL,NM_004448.3,NP_004439,P04626"
ERBB3,erb-b2 receptor tyrosine kinase 3,2065,12:56079861-56103505,1,"colon, gastric, head and neck, bladder, skin",,"CCDS31833.1,ENSG00000065361.15,HER3,LCCS2,NM_001982.3,NP_001973,P21860"
ERBB4,erb-b2 receptor tyrosine kinase 4,2066,2:211375717-212538841,1,"melanoma, gastric, NSCLC",,"ALS19,CCDS2394.1,ENSG00000178568.14,HER4,NM_005235.2,NP_005226,Q15303"
ERC1,ELKS/RAB6-interacting/CAST family member 1,23085,12:1027747-1495924,1,"papillary thyroid, Spitzoid tumour",,"CAST2,CCDS8508.1,ELKS,ENSG00000082805.19,KIAA1081,MGC12974,NM_178040.3,NP_829884,Q8IUD2,RAB6IP2"
ERCC2,"excision repair cross-complementing rodent repair deficiency, complementation group 2 (xeroderma pigmentosum D)",2068,19:45349837-45370587,1,,"skin basal cell, skin squamous cell, melanoma","CCDS33049.1,EM9,ENSG00000104884.15,MAG,MGC102762,MGC126218,MGC126219,NM_000400.3,NP_000391,P18074,TFIIH,XPD"
ERCC3,"excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing)",2071,2:127257290-127294176,1,,"skin basal cell, skin squamous cell, melanoma","BTF2,CCDS2144.1,ENSG00000163161.13,GTF2H,NM_001303418.1,NP_000113,NP_001290345.1,NP_001290347.1,P19447,RAD25,TFIIH,XPB"
ERCC4,"excision repair cross-complementing rodent repair deficiency, complementation group 4",2072,16:13920157-13952345,1,,"skin basal cell, skin squamous cell, melanoma","CCDS32390.1,ENSG00000175595.14,FANCQ,NM_005236.2,NP_005227,Q92889,RAD1,XPF"
ERCC5,"excision repair cross-complementing rodent repair deficiency, complementation group 5 (xeroderma pigmentosum, complementation group G (Cockayne syndrome))",2073,13:102844844-102876001,1,,"skin basal cell, skin squamous cell, melanoma","CCDS32004.1,ENSG00000134899.19,ERCM2,NM_000123.3,NP_000114,NP_000114.2,P28715,XPGC"
ERG,v-ets erythroblastosis virus E26 oncogene like (avian),2078,21:38380027-38661694,1,"Ewing sarcoma, prostate, AML",,"CCDS46648.1,ENSG00000157554.18,NM_001243432.2,NP_001129626,NP_001230361.1,P11308,erg-3,p55"
ESR1,estrogen receptor 1,2099,6:151690496-152103274,1,breast,,"CCDS5234.1,ENSG00000091831.23,ER-alpha,ESR,Era,NM_001122742.1,NP_001116214,NR3A1,P03372"
ETNK1,ethanolamine kinase 1,55500,12:22625075-22690665,1,"aCML, CMML, SM-AHD, HES",,"CCDS8698.1,EKI,EKI1,ENSG00000139163.15,NM_018638.4,NP_061108,Q9HBU6"
ETV1,ets variant gene 1,2115,7:13891228-13989946,1,"Ewing sarcoma, prostate",,"CCDS55088.1,ENSG00000006468.13,ER81,NM_004956.4,NP_004947,P50549"
ETV4,"ets variant gene 4 (E1A enhancer binding protein, E1AF)",2118,17:43527844-43546432,1,"Ewing sarcoma, prostate carcinoma",,"CCDS11465.1,E1A-F,E1AF,ENSG00000175832.12,NM_001079675.2,NP_001073143,P43268,PEA3"
ETV5,ets variant gene 5,2119,3:186046308-186109112,1,prostate,,"CCDS33906.1,ENSG00000244405.7,ERM,NM_004454.2,NP_004445,P41161"
ETV6,ets variant gene 6 (TEL oncogene),2120,12:11649854-11895402,1,"congenital fibrosarcoma, multiple different leukaemia and lymphoma tumour types including ALL, secretory breast, MDS",,"CCDS8643.1,ENSG00000139083.10,NM_001987.4,NP_001978,P41212,TEL"
EWSR1,Ewing sarcoma breakpoint region 1 (EWS),2130,22:29268316-29300343,1,"Ewing sarcoma, desmoplastic small round cell tumour , ALL, clear cell sarcoma, sarcoma, myoepithelioma, mesothelioma",,"CCDS13852.2,ENSG00000182944.17,EWS,NM_013986.3,NP_053733,Q01844"
EXT1,multiple exostoses type 1 gene,2131,8:117794490-118111853,1,,"exostoses, osteosarcoma","CCDS6324.1,ENSG00000182197.10,LGCR,LGS,NM_000127.2,NP_000118,Q16394,ttv"
EXT2,multiple exostoses type 2 gene,2132,11:44096197-44245429,1,,"exostoses, osteosarcoma","CCDS53618.1,ENSG00000151348.13,NM_000401.3,NP_000392,Q93063,SOTV"
EZH2,enhancer of zeste homolog 2,2146,7:148807385-148884278,1,DLBCL,,"CCDS5891.1,ENSG00000106462.10,ENX-1,EZH1,KMT6,KMT6A,NM_004456.4,NP_004447,Q15910"
EZR,ezrin,7430,6:158765748-158819412,1,NSCLC,,"CCDS5258.1,ENSG00000092820.17,NM_001111077.1,NP_001104547,P15311,VIL2"
FANCA,"Fanconi anemia, complementation group A",2175,16:89737549-89816646,1,,"AML, leukaemia","CCDS32515.1,ENSG00000187741.14,FA-H,FAA,FACA,FAH,FANCH,NM_000135.2,NP_000126,O15360"
FANCC,"Fanconi anemia, complementation group C",2176,9:95099054-95317702,1,,"AML, leukaemia","CCDS35071.1,ENSG00000158169.12,FA3,FAC,FACC,NM_000136.2,NP_000127,Q00597"
FANCD2,"Fanconi anemia, complementation group D2",2177,3:10026414-10099660,1,,"AML, leukaemia","CCDS2595.1,ENSG00000144554.10,FA-D2,FACD,FAD,FANCD,NM_033084.4,NP_149075,Q9BXW9"
FANCE,"Fanconi anemia, complementation group E",2178,6:35452361-35467103,1,,"AML, leukaemia","CCDS4805.1,ENSG00000112039.3,FACE,FAE,NM_021922.2,NP_068741,Q9HB96"
FANCF,"Fanconi anemia, complementation group F",2188,11:22622519-22626787,1,,"AML, leukaemia","CCDS7857.1,ENSG00000183161.4,FAF,NM_022725.3,NP_073562,Q9NPI8"
FANCG,"Fanconi anemia, complementation group G",2189,9:35073838-35080016,1,,"AML, leukaemia","CCDS6574.1,ENSG00000221829.9,FAG,NM_004629.1,NP_004620,O15287,XRCC9"
FAS,Fas cell surface death receptor,355,10:88990657-89015785,1,"TGCT, nasal NK/T lymphoma, skin squamous cell carcinoma-burn scar related",,"APO-1,APT1,CCDS7393.1,CD95,ENSG00000026103.21,FAS1,NM_000043.5,NP_000034,P25445,TNFRSF6"
FAT1,FAT atypical cadherin 1,2195,4:186587783-186723855,1,"oral squamous cell, chemorefractory CLL, head and neck, pancreatic acinar cell carcinoma",pancreatic,"CCDS47177.1,CDHF7,CDHR8,ENSG00000083857.13,FAT,NM_005245.3,NP_005236,Q14517"
FAT4,FAT atypical cadherin 4,79633,4:125316399-125492932,1,"lymphoma, pancreatic, head and neck, melanoma, hepatocellular carcinoma",,"CCDS3732.3,CDHF14,CDHR11,ENSG00000196159.11,FAT-J,NM_024582.4,NP_078858,NP_001278214.1,NP_001278232.1,Q6V0I7"
FBXO11,F-box protein 11,80204,2:47806920-47905793,1,DLBCL,,"CCDS54357.1,ENSG00000138081.20,FBX11,NM_001190274.1,NP_001177203,Q86XK2,UBR6"
FBXW7,"F-box and WD-40 domain protein 7 (archipelago homolog, Drosophila)",55294,4:152320544-152536063,1,"colorectal, endometrial, T-ALL",,"AGO,CCDS3777.1,CDC4,ENSG00000109670.14,FBW7,FBX30,FBXW6,FLJ11071,NM_033632.3,NP_361014,Q969H0,SEL-10,SEL10"
FCGR2B,"Fc fragment of IgG, low affinity IIb, receptor for (CD32)",2213,1:161663161-161678654,1,ALL,,"CCDS30924.1,CD32,CD32B,ENSG00000072694.20,FCG2,FCGR2,NM_004001.4,NP_003992,NP_001002275.1,P31994"
FCRL4,Fc receptor-like 4,83417,1:157573749-157598080,1,B-NHL,,"CCDS1166.1,CD307d,ENSG00000163518.10,FCRH4,IGFP2,IRTA1,NM_031282.2,NP_112572,Q96PJ5"
FES,"FES proto-oncogene, tyrosine kinase",2242,15:90884412-90895776,1,"HNSCC, ovarian carcinoma",,"CCDS10365.1,ENSG00000182511.11,FPS,NM_002005.3,NP_001996,P07332"
FEV,FEV protein - (HSRNAFEV),54738,2:218981087-218985657,1,Ewing sarcoma,,"CCDS2428.1,ENSG00000163497.2,NM_017521.2,NP_059991,Pet-1,Q99581"
FGFR1,fibroblast growth factor receptor 1,2260,8:38411138-38467845,1,"MPN, NHL, salivary adenoma",,"BFGFR,CCDS55223.1,CD331,CEK,ENSG00000077782.19,FLG,FLT2,H2,H3,H4,H5,KAL2,N-SAM,NM_001174067.1,NP_001167538,P11362"
FGFR1OP,FGFR1 oncogene partner (FOP),11116,6:166999182-167052713,1,"MPN, NHL",,"CCDS5296.1,ENSG00000213066.12,FOP,NM_007045.3,NP_008976,O95684"
FGFR2,fibroblast growth factor receptor 2,2263,10:121479857-121598403,1,"gastric, NSCLC, endometrial",,"BEK,CCDS7620.2,CD332,CEK3,CFD1,ECT1,ENSG00000066468.22,JWS,K-SAM,KGFR,NM_022970.3,NP_075259,P21802,TK14,TK25"
FGFR3,fibroblast growth factor receptor 3,2261,4:1793312-1808872,1,"bladder, MM, T-cell lymphoma",,"ACH,CCDS54706.1,CD333,CEK2,ENSG00000068078.18,JTK4,NM_001163213.1,NP_001156685.1,P22607"
FGFR4,fibroblast growth factor receptor 4,2264,5:177086886-177098144,1,rhabdomyosarcoma,,"CCDS4410.1,CD334,ENSG00000160867.14,JTK2,NM_213647.2,NP_998812,NP_002002,NP_001341913.1,P22455"
FH,fumarate hydratase,2271,1:241497603-241519761,1,,"leiomyomatosis, renal","CCDS1617.1,ENSG00000091483.6,NM_000143.3,NP_000134,P07954"
FHIT,fragile histidine triad gene,2272,3:59751407-61251459,1,pleomorphic salivary gland adenoma,,"AP3Aase,CCDS2894.1,ENSG00000189283.9,FRA3B,NM_001320900.1,NP_001307828,NP_001307829,P49789"
FIP1L1,FIP1 like 1 (S. cerevisiae),81608,4:53377645-53459668,1,idiopathic hypereosinophilic syndrome,,"CCDS3491.1,DKFZp586K0717,ENSG00000145216.15,FIP1,NM_030917.3,NP_112179,Q6UN15"
FLCN,folliculin,201163,17:17212212-17237139,1,,"renal, fibrofolliculomas, trichodiscomas","BHD,CCDS32579.1,ENSG00000154803.12,MGC17998,MGC23445,NM_144997.5,NP_659434,NP_001340160.1,NP_001340159.1,Q8NFG4"
FLI1,Friend leukemia virus integration 1,2313,11:128693770-128813267,1,Ewing sarcoma,,"CCDS44768.1,ENSG00000151702.16,EWSR2,NM_002017.4,NP_002008,Q01543,SIC-1"
FLT3,fms-related tyrosine kinase 3,2322,13:28003274-28100592,1,"AML, ALL",,"CCDS31953.1,CD135,ENSG00000122025.14,FLK2,NM_004119.2,NP_004110,P36888,STK1"
FLT4,fms-related tyrosine kinase 4,2324,5:180601506-180649624,1,soft tissue sarcoma,,"CCDS4457.1,ENSG00000037280.15,NM_182925.4,NP_891555,P35916,PCL,VEGFR3"
FOXA1,forkhead box A1,3169,14:37589984-37595034,1,"breast, prostate",,"CCDS9665.1,ENSG00000129514.5,HNF3A,NM_004496.3,NP_004487,P55317"
FOXL2,forkhead box L2,668,3:138944224-138947140,1,granulosa-cell tumour of the ovary,,"BPES,BPES1,CCDS3105.1,ENSG00000183770.5,NM_023067.3,NP_075555,P58012"
FOXO1,forkhead box O1,2308,13:40555667-40666597,1,alveolar rhabdomyosarcoma,,"CCDS9371.1,ENSG00000150907.7,FKH1,FKHR,FOXO1A,NM_002015.3,NP_002006,Q12778"
FOXO3,forkhead box O3,2309,6:108560866-108684768,1,AL,,"AF6q21,CCDS5068.1,ENSG00000118689.14,FKHRL1,FOXO2,FOXO3A,NM_001455.3,NP_001446,O43524"
FOXO4,forkhead box O4,4303,X:71096197-71103535,1,"AL, soft tissue sarcoma",,"AFX1,CCDS43969.1,ENSG00000184481.16,MLLT7,NM_005938.3,NP_005929,P98177"
FOXP1,forkhead box P1,27086,3:70954715-71583989,1,ALL,,"12CC4,CCDS74964.1,ENSG00000114861.19,HSPC215,NM_001244810.1,NP_001231739,Q9H334,QRF1,hFKH1B"
FSTL3,follistatin-like 3 (secreted glycoprotein),10272,19:676365-683399,1,B-CLL,,"CCDS12040.1,ENSG00000070404.9,FLRG,FSRP,NM_005860.2,NP_005851,O95633"
FUBP1,far upstream element (FUSE) binding protein 1,8880,1:77948405-77979086,1,oligodendroglioma,,"CCDS683.1,ENSG00000162613.16,FBP,FUBP,NM_003902.4,NP_003893,NP_001290362.1,Q96AE4"
FUS,"fusion, derived from t(12;16) malignant liposarcoma",2521,16:31180110-31194871,1,"liposarcoma, AML, Ewing sarcoma, angiomatoid fibrous histiocytoma, fibromyxoid sarcoma",,"ALS6,CCDS10707.1,ENSG00000089280.18,FUS1,HNRNPP2,NM_004960.3,NP_004951,NP_001164408.1,P35637,TLS,hnRNP-P2"
GAS7,growth arrest-specific 7,8522,17:9913850-10198551,1,AML*,,"CCDS11152.1,ENSG00000007237.18,KIAA0394,MGC1348,NM_201433.1,NP_958839,O60861"
GATA1,GATA binding protein 1 (globin transcription factor 1),2623,X:48786554-48794308,1,megakaryoblastic leukaemia of Downs syndrome,,"CCDS14305.1,ENSG00000102145.13,ERYF1,GATA-1,GF1,NF-E1,NFE1,NM_002049.3,NP_002040,P15976"
GATA2,GATA binding protein 2,2624,3:128479427-128493185,1,AML (CML blast transformation),,"CCDS3049.1,ENSG00000179348.11,NFE1B,NM_032638.4,NP_116027,P23769"
GATA3,GATA binding protein 3,2625,10:8054653-8075203,1,breast,,"CCDS31143.1,ENSG00000107485.16,HDR,NM_001002295.1,NP_001002295,P23771"
GNA11,"guanine nucleotide binding protein (G protein), alpha 11 (Gq class)",2767,19:3094410-3124004,1,"uveal melanoma, primary central nervous system melanocytic neoplasms",,"CCDS12103.1,ENSG00000088256.8,FBH,FBH2,FHH2,HHC2,NM_002067.4,NP_002058,P29992"
GNAQ,"guanine nucleotide binding protein (G protein), q polypeptide",2776,9:77716087-78031458,1,"uveal melanoma, primary central nervous system melanocytic neoplasms",,"CCDS6658.1,ENSG00000156052.10,G-ALPHA-q,GAQ,NM_002072.4,NP_002063,P50148"
GNAS,"guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1",2778,20:58852714-58911192,1,"pituitary adenoma, pancreatic intraductal papillary mucinous neoplasm, fibrous dysplasia",,"CCDS46622.1,ENSG00000087460.24,GNAS1,GNASXL,GPSA,NESP,NESP55,NM_080425.3,NP_536350,Q5JWF2,SCG6,SgVI"
GOLGA5,"golgi autoantigen, golgin subfamily a, 5  (PTC5)",9950,14:92794231-92839963,1,"papillary thyroid, Spitzoid tumour",,"CCDS9905.1,ENSG00000066455.12,GOLIM5,NM_005113.3,NP_005104,NP_005104.3,Q8TBA6,golgin-84,ret-II,rfg5"
GOPC,golgi associated PDZ and coiled-coil motif containing,57120,6:117560269-117602364,1,"glioblastoma, cholangiocarcinoma, borderline ovarian",,"CAL,CCDS5117.1,ENSG00000047932.13,FIG,GOPC1,NM_020399.3,NP_065132,PIST,Q9HD26,dJ94G16.2"
GPC3,glypican 3,2719,X:133535754-133985646,1,,Wilms tumour,"CCDS55496.1,DGSX,ENSG00000147257.13,NM_001164617.1,NP_001158089,OCI-5,P51654,SDYS,SGB,SGBS,SGBS1"
GPHN,gephyrin (GPH),10243,14:66507407-67181803,1,AL,,"CCDS9777.1,ENSG00000171723.15,KIAA1385,NM_020806.4,NP_065857,Q9NQX3"
GRIN2A,"glutamate receptor, ionotropic, N-methyl D-aspartate 2A",2903,16:9753404-10182754,1,"melanoma, colorectal carcinoma, gastric carcinoma, lung carcinoma",,"CCDS10539.1,ENSG00000183454.16,GluN2A,NMDAR2A,NM_000833.4,NP_000824,Q12879"
H3F3A,"H3 histone, family 3A",3020,1:226063977-226072001,1,glioma,,"CCDS1550.1,ENSG00000163041.9,H3.3A,H3F3,P84243"
H3F3B,"H3 histone, family 3B (H3.3B)",3021,17:75776434-75779779,1,chondroblastoma,,"CCDS11729.1,ENSG00000132475.10,H3.3B,NM_005324.4,NP_005315,P84243"
HERPUD1,"homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1",9709,16:56932048-56944863,1,prostate,,"CCDS10771.1,ENSG00000051108.14,HERP,KIAA0025,Mif1,NM_014685.3,NP_055500,NP_001259032.1,Q15011,SUP"
HEY1,hairy/enhancer-of-split related with YRPW motif 1,23462,8:79764013-79767857,1,mesenchymal chondrosarcoma,,"CCDS43749.1,CHF-2,CHF2,ENSG00000164683.16,HERP2,HESR-1,HESR1,HRT-1,NM_001040708.1,NP_001035798,Q9Y5J3,bHLHb31"
HIF1A,hypoxia inducible factor 1 alpha subunit,3091,14:61697622-61748259,1,"endometrioid carcinoma, glioblastoma, colorectal, renal, lung, pancreatic",,"CCDS58324.1,ENSG00000100644.16,HIF-1alpha,HIF1,MOP1,NM_001243084.1,NP_001230013,PASD8,Q16665,bHLHe78"
HIP1,huntingtin interacting protein 1,3092,7:75533300-75738947,1,"CMML, NSCLC",,"CCDS34669.1,ENSG00000127946.16,ILWEQ,NM_005338.6,NP_005329,O00291"
HIST1H3B,"histone cluster 1, H3b",8358,6:26031650-26032060,1,glioma,,"CCDS4573.1,ENSG00000274267.1,H3/l,H3FL,NM_003537.3,NP_003528,P68431"
HIST1H4I,"histone 1, H4i (H4FM)",8294,6:27138588-27139881,1,NHL,,"CCDS4620.1,ENSG00000276180.1,H4/m,H4FM,NM_003495.2,NP_003486,P62805"
HLA-A,"major histocompatibility complex, class I, A",3105,6:29941260-29945884,1,Spitzoid tumour,,"CCDS34373.1,ENSG00000206503.12,P04439,P13746,P16188"
HLF,hepatic leukemia factor,3131,17:55265012-55325065,1,ALL,,"CCDS11585.1,ENSG00000108924.13,MGC33822,NM_002126.4,NP_002117,Q16534"
HMGA1,high mobility group AT-hook 1,3159,6:34236873-34246230,1,"microfollicular thyroid adenoma, various benign mesenchymal tumours",,"CCDS4789.1,ENSG00000137309.19,HMGIY,NM_145901.2,NP_665908,NP_001306010,NP_001306007,P17096"
HMGA2,high mobility group AT-hook 2 (HMGIC),8091,12:65824460-65915447,1,"lipoma, leiomyoma, pleomorphic salivary gland adenoma",,"BABL,CCDS73491.1,ENSG00000149948.13,HMGIC,LIPO,NM_001300919.1,NP_001287848"
HNF1A,HNF1 homeobox A,6927,12:120978749-121001269,1,"hepatic adenoma, hepatocellular","hepatic adenoma, hepatocellular carcinoma","CCDS76611.1,ENSG00000135100.17,HNF1,LFB1,MODY3,NM_001306179.1,NP_001293108,NP_001293108.1,TCF1"
HNRNPA2B1,heterogeneous nuclear ribonucleoprotein A2/B1,3181,7:26189927-26200746,1,prostate,,"CCDS43557.1,ENSG00000122566.20,HNRPA2B1,NM_031243.2,NP_112533,P22626"
HOOK3,hook homolog 3,84376,8:42896932-43030539,1,papillary thyroid,,"CCDS6139.1,ENSG00000168172.8,HK3,NM_032410.3,NP_115786,Q86VS8"
HOXA11,homeo box A11,3207,7:27181515-27185216,1,CML,,"CCDS5411.1,ENSG00000005073.5,HOX1,HOX1I,NM_005523.5,NP_005514,P31270"
HOXA13,homeo box A13,3209,7:27194364-27200106,1,AML,,"CCDS5412.1,ENSG00000106031.7,HOX1,HOX1J,NM_000522.4,NP_000513,P31271"
HOXA9,homeo box A9,3205,7:27162435-27165530,1,AML*,,"CCDS5409.1,ENSG00000078399.17,HOX1,HOX1G,NM_152739.3,NP_689952,P31269"
HOXC11,homeo box C11,3227,12:53973126-53977643,1,AML,,"CCDS8867.1,ENSG00000123388.4,HOX3H,NM_014212.3,NP_055027,O43248"
HOXC13,homeo box C13,3229,12:53938765-53946544,1,AML,,"CCDS8865.1,ENSG00000123364.4,HOX3,HOX3G,NM_017410.2,NP_059106,P31276"
HOXD11,homeo box D11,3237,2:176107286-176109588,1,AML,,"CCDS2265.1,ENSG00000128713.13,HOX4,HOX4F,NM_021192.2,NP_067015,P31277"
HOXD13,homeo box D13,3239,2:176092891-176095938,1,AML*,,"CCDS2264.2,ENSG00000128714.5,HOX4I,NM_000523.3,NP_000514,P35453,SPD"
HRAS,v-Ha-ras Harvey rat sarcoma viral oncogene homolog,3265,11:532243-535550,1,"infrequent sarcomas, rare other tumour types","rhabdomyosarcoma, ganglioneuroblastoma, bladder","CCDS7698.1,ENSG00000174775.16,HRAS1,NM_005343.3,NP_001123914,NP_005334,NP_001304983.1,P01112"
HSP90AA1,"heat shock protein 90kDa alpha (cytosolic), class A member 1",3320,14:102081049-102139686,1,NHL,,"CCDS32160.1,ENSG00000080824.18,FLJ31884,HSP90N,HSPC1,HSPCA,Hsp89,Hsp90,NM_001017963.2,NP_001017963,P07900"
HSP90AB1,"heat shock protein 90kDa alpha (cytosolic), class B member 1",3326,6:44247866-44253883,1,NHL,,"CCDS4909.1,ENSG00000096384.19,HSPC2,HSPCB,P08238"
IDH1,"isocitrate dehydrogenase 1 (NADP+), soluble",3417,2:208236265-208254322,1,glioblastoma,,"CCDS2381.1,ENSG00000138413.13,NM_001282387.1,NP_001269316,O75874"
IDH2,"isocitrate dehydrogenase 2 (NADP+), mitochondrial",3418,15:90083045-90102504,1,glioblastoma,,"CCDS10359.1,ENSG00000182054.9,NM_002168.3,NP_002159,P48735"
IGH,immunoglobulin heavy locus,3492,14:-,1,"MM, Burkitt lymphoma, NHL, CLL, B-ALL, MALT, MLCLS",,
IGK,immunoglobulin kappa locus,50802,2:-,1,"Burkitt lymphoma, B-NHL",,
IGL,immunoglobulin lambda locus,3535,22:-,1,Burkitt lymphoma,,
IKBKB,"inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta",3551,8:42271302-42331608,1,SMZL,,"CCDS6128.1,ENSG00000104365.13,IKK-beta,IKK2,IKKB,NFKBIKB,NM_001556.2,NP_001547,O14920"
IKZF1,IKAROS family zinc finger 1,10320,7:50304669-50405101,1,"ALL, DLBCL",,"CCDS75596.1,ENSG00000185811.18,Hs.54452,IKAROS,LyF-1,NM_006060.5,NP_006051,PPP1R92,ZNFN1A1,hIk-1"
IKZF3,IKAROS Family Zinc Finger 3,22806,17:39757715-39864188,1,"B-ALL, CLL, breast cancer, colorectal cancer",,"Aiolos,CCDS11346.1,ENSG00000161405.16,NM_012481.4,NP_036613,Q9UKT9,ZNFN1A3"
IL2,interleukin 2,3558,4:122451470-122456725,1,intestinal T-cell lymphoma,,"CCDS3726.1,ENSG00000109471.4,IL-2,NM_000586.3,NP_000577,P60568,TCGF"
IL21R,interleukin 21 receptor,50615,16:27402162-27452042,1,NHL,,"CCDS10630.1,CD360,ENSG00000103522.15,NM_181078.2,NP_851564,Q9HBE5"
IL6ST,"interleukin 6 signal transducer (gp130, oncostatin M receptor)",3572,5:55935095-55994993,1,hepatocellular carcinoma,,"CCDS3971.1,CD130,ENSG00000134352.19,GP130,NM_002184.3,NP_002175,P40189"
IL7R,interleukin 7 receptor,3575,5:35856849-35879603,1,"ALL, ETP ALL",,"CCDS3911.1,CD127,ENSG00000168685.14,IL7RA,NM_002185.3,NP_002176,P16871"
IRF4,interferon regulatory factor 4,3662,6:391739-411447,1,MM,,"CCDS4469.1,ENSG00000137265.14,LSIRF,MUM1,NM_002460.3,NP_002451,NP_001182215.1,Q15306"
IRS4,insulin receptor substrate 4,8471,X:108732482-108736409,1,"glioma, rhabdomyosarcoma, melanoma, breast cancer, T-ALL",,"CCDS14544.1,ENSG00000133124.11,IRS-4,NM_003604.2,NP_003595,O14654,PY160"
ITK,IL2-inducible T-cell kinase,3702,5:157180826-157255191,1,peripheral T-cell lymphoma,,"CCDS4336.1,EMT,ENSG00000113263.12,LYK,NM_005546.3,NP_005537,PSCTK2,Q08881"
JAK1,Janus kinase 1,3716,1:64833229-64966504,1,ALL,,"CCDS41346.1,ENSG00000162434.11,JAK1A,JAK1B,JTK3,NM_002227.3,NP_002218,NP_001308782,NP_001307852,NP_001308784,NP_001308785,NP_001308781,NP_001308783,NP_001308786.1,P23458"
JAK2,Janus kinase 2,3717,9:4985245-5128183,1,"ALL, AML, MPN,  CML",,"CCDS6457.1,ENSG00000096968.13,JTK10,NM_004972.3,NP_004963,NP_001309125,NP_001309123,NP_001309124,NP_001309133.1,NP_001309127.1,NP_001309128.1,O60674"
JAK3,Janus kinase 3,3718,19:17824786-17848032,1,"acute megakaryocytic leukaemia, ETP ALL",,"CCDS12366.1,ENSG00000105639.18,JAK-3,JAK3_HUMAN,JAKL,L-JAK,LJAK,NM_000215.3,NP_000206,P52333"
JUN,jun oncogene,3725,1:58780788-58784327,1,sarcoma,,"AP-1,CCDS610.1,ENSG00000177606.6,NM_002228.3,NP_002219,P05412,c-Jun"
KAT6A,K(lysine) acetyltransferase 6A,7994,8:41929479-42051987,1,AML,,"CCDS6124.1,ENSG00000083168.9,MOZ,MYST3,Q92794,RUNXBP2,ZC2HC6A,ZNF220"
KAT6B,K(lysine) acetyltransferase 6B,23522,10:74826625-75032622,1,"AML, leiomyoma",,"CCDS7345.1,ENSG00000156650.12,MOZ2,MYST4,Morf,NM_012330.3,NP_036462,Q8WYB5,ZC2HC6B,qkf,querkopf"
KCNJ5,"potassium inwardly-rectifying channel; subfamily J; member 5",3762,11:128891356-128921035,1,adrenal adenoma,,"CCDS8479.1,CIR,ENSG00000120457.11,GIRK4,KATP1,Kir3.4,LQT13,NM_001354169.1,NP_000881,NP_001341098.1,P48544"
KDM5A,"lysine (K)-specific demethylase 5A, JARID1A",5927,12:280129-389454,1,AML,,"CCDS41736.1,ENSG00000073614.12,JARID1A,NM_001042603.2,NP_001036068,P29375,RBBP2"
KDM5C,lysine (K)-specific demethylase 5C (JARID1C),8242,X:53192152-53225422,1,clear cell renal carcinoma,,"CCDS14351.1,DXS1272E,ENSG00000126012.11,JARID1C,MRX13,NM_004187.3,NP_004178,P41229,SMCX,XE169"
KDM6A,"lysine (K)-specific demethylase 6A, UTX",7403,X:44873511-45112602,1,"renal cell carcinoma, bladder carcinoma, oesophageal SCC, MM, medulloblastoma, T-ALL, other tumour types",,"CCDS14265.1,ENSG00000147050.14,NM_021140.3,NP_066963,O15550,UTX"
KDR,vascular endothelial growth factor receptor 2,3791,4:55078259-55125595,1,"NSCLC, angiosarcoma",melanoma,"CCDS3497.1,CD309,ENSG00000128052.9,FLK1,NM_002253.2,NP_002244,VEGFR,VEGFR2"
KDSR,3-ketodihydrosphingosine reductase,2531,18:63327726-63367510,1,B-NHL,,"CCDS11982.1,DHSR,ENSG00000119537.16,FVT1,Q06136,SDR35C1"
KEAP1,kelch like ECH associated protein 1,9817,19:10486120-10503741,1,"NSCLC, breast carcinoma",,"CCDS12239.1,ENSG00000079999.13,INrf2,KIAA0132,KLHL19,MGC10630,MGC1114,MGC20887,MGC4407,MGC9454,NM_203500.1,NP_987096,Q14145"
KIF5B,kinesin family member 5B,3799,10:32009010-32056431,1,"NSCLC, Spitzoid tumour",,"CCDS7171.1,ENSG00000170759.10,KNS,KNS1,NM_004521.2,NP_004512,P33176"
KIT,v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog,3815,4:54657918-54740715,1,"GIST, AML, TGCT, mastocytosis, mucosal melanoma","GIST, epithelioma","C-Kit,CCDS3496.1,CD117,ENSG00000157404.15,NM_000222.2,NP_000213,P10721,PBT,SCFR"
KLF4,Kruppel-like factor 4,9314,9:107484852-107489646,1,meningioma,,"CCDS6770.2,ENSG00000136826.14,EZF,GKLF,NM_004235.5,NP_004226,NP_001300981.1,O43474"
KLF6,Kruppel-like factor 6,1316,10:3775996-3785275,1,"prostate, glioma",,"BCD1,CCDS7060.1,COPEB,CPBP,ENSG00000067082.14,GBF,NM_001300.5,NP_001291,NP_001153596.1,PAC1,Q99612,ST12,Zf9"
KLK2,kallikrein-related peptidase 2,3817,19:50873249-50880567,1,prostate,,"CCDS12808.1,ENSG00000167751.12,NM_005551.4,NP_005542,P20151"
KMT2A,lysine (K)-specific methyltransferase 2A,4297,11:118436490-118526832,1,"AML, ALL",,"ALL-1,CCDS55791.1,CXXC7,ENSG00000118058.20,HRX,HTRX1,MLL,MLL1A,NM_001197104.1,NP_001184033,Q03164,TRX1"
KMT2C,lysine (K)-specific methyltransferase 2C,58508,7:152134925-152436005,1,medulloblastoma,,"CCDS5931.1,ENSG00000055609.17,HALR,KIAA1506,MLL3,NM_170606.2,NP_733751,Q8NEZ4"
KMT2D,lysine (K)-specific methyltransferase 2D,8085,12:49018975-49055324,1,"medulloblastoma, renal",,"ALR,CAGL114,CCDS44873.1,ENSG00000167548.14,MLL2,MLL4,NM_003482.3,NP_003473,O14686,TNRC21"
KNL1,cancer susceptibility candidate 5,57082,15:40594020-40664342,1,AML,,"AF15Q14,CASC5,CCDS42023.1,CT29,D40,ENSG00000137812.19,KIAA1570,MCPH4,NM_170589.4,NP_733468,PPP1R55,Q8NG31,Spc7,hKNL-1,hSpc105"
KRAS,v-Ki-ras2 Kirsten rat sarcoma 2 viral oncogene homolog,3845,12:25209431-25250803,1,"pancreatic, colorectal, lung, thyroid, AML, other tumour types",,"CCDS8703.1,ENSG00000133703.11,KRAS1,KRAS2,NM_033360.3,NP_203524,P01116"
KTN1,kinectin 1 (kinesin receptor),3895,14:55580317-55684579,1,papillary thyroid,,"CCDS41957.1,CG1,ENSG00000126777.17,KIAA0004,KNT,NM_001271014.1,NP_001072989,NP_001257943.1,Q86UP2"
LASP1,LIM and SH3 protein 1,3927,17:38869859-38921770,1,AML,,"CCDS11331.1,ENSG00000002834.17,Lasp-1,MLN50,NM_006148.3,NP_006139,Q14847"
LATS1,large tumor suppressor kinase 1,9113,6:149658153-149718256,1,skin basal cell carcinoma,,"CCDS34551.1,ENSG00000131023.12,NM_004690.3,NP_004681,O95835,WARTS"
LATS2,large tumor suppressor kinase 2,26524,13:20973032-21061547,1,malignant mesothelioma,,"CCDS9294.1,ENSG00000150457.8,NM_014572.2,NP_055387,Q9NRM7"
LCK,lymphocyte-specific protein tyrosine kinase,3932,1:32251239-32286165,1,T-ALL,,"CCDS359.1,ENSG00000182866.16,NM_005356.4,NP_005347,P06239"
LEF1,lymphoid enhancer binding factor 1,51176,4:108047545-108168422,1,"B-ALL, T-ALL, eyelid sebaceous carcinoma, AML, lymphomas",,"CCDS3679.1,ENSG00000138795.9,NM_016269.4,NP_057353,Q9UJU2,TCF10,TCF1ALPHA,TCF7L3"
LIFR,leukemia inhibitory factor receptor,3977,5:38474963-38595404,1,salivary adenoma,,"CCDS3927.1,CD118,ENSG00000113594.9,NM_002310.5,NP_002301,P42702"
LMNA,lamin A/C,4000,1:156114707-156140089,1,Spitzoid tumour,,"CCDS1129.1,CMD1A,ENSG00000160789.19,HGPS,LGMD1B,LMN1,LMNL1,MADA,NM_170707.3,NP_733821,P02545,PRO1"
LMO1,LIM domain only 1 (rhombotin 1) (RBTN1),4004,11:8224304-8263858,1,"T-ALL, neuroblastoma",neuroblastoma,"CCDS44534.1,ENSG00000166407.13,NM_002315.2,NP_002306,P25800,RBTN1,RHOM1,TTG1"
LMO2,LIM domain only 2 (rhombotin-like 1) (RBTN2),4005,11:33858576-33892289,1,T-ALL,,"CCDS7888.2,ENSG00000135363.11,NM_005574.3,NP_005565,P25791,RBTN2,RBTNL1,RHOM2,TTG2"
LPP,LIM domain containing preferred translocation partner in lipoma,4026,3:188212933-188890671,1,"lipoma, leukaemia",,"CCDS3291.1,ENSG00000145012.13,NM_005578.4,NP_005569,Q93052"
LRIG3,leucine-rich repeats and immunoglobulin-like domains 3,121227,12:58872149-58920522,1,NSCLC,,"CCDS8960.1,ENSG00000139263.11,FLJ90440,KIAA3016,NM_153377.4,NP_700356,Q6UXM1"
LRP1B,LDL receptor related protein 1B,53353,2:140231423-142131701,1,"CLL, ovarian cancer, oesophageal squamous cell carcinoma, urothelial cancer",,"CCDS2182.1,ENSG00000168702.17,LRP-DIT,LRPDIT,NM_018557.2,NP_061027,Q9NZR2"
LYL1,lymphoblastic leukemia derived sequence 1,4066,19:13099033-13102867,1,T-ALL,,"CCDS12292.1,ENSG00000104903.4,NM_005583.4,NP_005574,P12980,bHLHa18"
LZTR1,leucine-zipper-like transcription regulator 1,8216,22:20982013-20999038,1,glioblastoma,"glioblastoma, schwannoma","BTBD29,CCDS33606.1,ENSG00000099949.19,LZTR-1,Q8N653"
MAF,v-maf musculoaponeurotic fibrosarcoma oncogene homolog,4094,16:79593838-79600714,1,MM,,"CCDS10928.1,ENSG00000178573.6,NM_005360.4,NP_005351,O75444,c-MAF"
MAFB,v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian),9935,20:40685848-40689240,1,MM,,"CCDS13311.1,ENSG00000204103.3,KRML,NM_005461.4,NP_005452,Q9Y5Q3"
MALT1,mucosa associated lymphoid tissue lymphoma translocation gene 1,10892,18:58671386-58754477,1,MALT,,"CCDS11967.1,ENSG00000172175.12,MLT,NM_006785.3,NP_006776,PCASP1,Q9UDY8"
MAML2,mastermind-like 2 (Drosophila),84441,11:95976598-96343180,1,salivary gland mucoepidermoid,,"CCDS44714.1,ENSG00000184384.13,KIAA1819,MAM3,NM_032427.3,NP_115803,Q8IZL2"
MAP2K1,mitogen-activated protein kinase kinase 1,5604,15:66386817-66492312,1,"NSCLC, melanoma, colorectal",,"CCDS10216.1,ENSG00000169032.9,MAPKK1,MEK1,NM_002755.3,NP_002746,PRKMK1,Q02750"
MAP2K2,mitogen-activated protein kinase kinase 2,5605,19:4090321-4124129,1,"NSCLC, melanoma",,"CCDS12120.1,ENSG00000126934.13,MEK2,NM_030662.3,NP_109587,P36507,PRKMK2"
MAP2K4,mitogen-activated protein kinase kinase 4,6416,17:12020834-12143830,1,"pancreatic, breast, colorectal",,"CCDS62095.1,ENSG00000065559.14,JNKK1,MEK4,MKK4,NM_001281435.1,NP_001268364,P45985,PRKMK4,SERK1"
MAP3K1,"mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase",4214,5:56815574-56896152,1,luminal A breast,,"CCDS43318.1,ENSG00000095015.5,MAPKKK1,MEKK,MEKK1,NM_005921.1,NP_005912,Q13233"
MAP3K13,mitogen-activated protein kinase kinase kinase 13,9175,3:185363120-185489097,1,breast,,"CCDS3270.1,ENSG00000073803.13,LZK,MEKK13,NM_004721.4,NP_004712,O43283"
MAPK1,mitogen-activated protein kinase 1,5594,22:21754500-21867629,1,"CLL, ovarian mixed germ cell tumour, cervical carcinoma",,"CCDS13795.1,ENSG00000100030.14,ERK,ERK2,MAPK2,NM_002745.4,NP_002736,P28482,PRKM1,PRKM2,p41mapk"
MAX,Myc associated factor X,4149,14:65075544-65102470,1,"pheochromocytoma, endometrioid carcinoma, colon carcinoma",pheochromocytoma,"CCDS9771.1,ENSG00000125952.18,NM_002382.4,NP_002373,P61244,bHLHd4,bHLHd5,bHLHd6,bHLHd7,bHLHd8"
MDM2,Mdm2 p53 binding protein homolog,4193,12:68808176-68850686,1,"sarcoma, glioma, colorectal, other tumour types",,"CCDS8986.2,ENSG00000135679.23,HDM2,MGC5370,NM_002392.5,NP_002383,Q00987"
MDM4,Mdm4 p53 binding protein homolog,4194,1:204516383-204558120,1,"glioblastoma, bladder, retinoblastoma",,"CCDS1447.1,ENSG00000198625.12,HDMX,MDMX,NM_002393.4,NP_002384,O15151"
MECOM,MDS1 and EVI1 complex locus,2122,3:169083499-169146305,1,"AML, CML, MDS",,"CCDS54670.1,ENSG00000085276.17,EVI1,KMT8E,MDS1,MDS1-EVI1,NM_001105077.3,NP_001098547,PRDM3,Q03112"
MED12,mediator complex subunit 12,9968,X:71118723-71142447,1,"uterine leiomyoma, fibroadenoma, phyllodes tumour",,"CAGH45,CCDS43970.1,ENSG00000184634.15,FGS1,HOPA,KIAA0192,NM_005120.2,NP_005111,OKS,OPA1,Q93074,TNRC11,TRAP230"
MEN1,multiple endocrine neoplasia type 1 gene,4221,11:64803524-64811294,1,"parathyroid tumours, pancreatic neuroendocrine tumour","parathyroid adenoma, pituitary adenoma, pancreatic islet cell, carcinoid","CCDS8083.1,ENSG00000133895.14,NM_130803.2,NP_570715,NP_570715.1,O00255"
MET,met proto-oncogene (hepatocyte growth factor receptor),4233,7:116672405-116796342,1,"papillary renal, head-neck squamous cell",papillary renal,"CCDS47689.1,DFNB97,ENSG00000105976.14,HGFR,NM_001127500.2,NP_001120972,P08581,RCCP2"
MITF,melanogenesis-associated transcription factor,4286,3:69739435-69968336,1,melanoma,,"CCDS43106.1,ENSG00000187098.15,MI,NM_198159.2,NP_937802,NP_001341534.1,NP_001341535.1,NP_001341533.1,O75030,WS2,WS2A,bHLHe32"
MLF1,myeloid leukemia factor 1,4291,3:158582835-158606459,1,AML,,"CCDS56286.1,ENSG00000178053.17,NM_001195432.1,NP_001182361,P58340"
MLH1,E.coli MutL homolog gene,4292,3:36993332-37050918,1,"colorectal, endometrial, ovarian, CNS tumours","colorectal, endometrial, ovarian, CNS","CCDS2663.1,COCA2,ENSG00000076242.14,FCC2,HNPCC,HNPCC2,NM_001354620.1,NP_000240,NP_001341546.1,NP_001341549.1,P40692"
MLLT1,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 1 (ENL)",4298,19:6210379-6279948,1,AL,,"CCDS12160.1,ENL,ENSG00000130382.8,LTG19,NM_005934.3,NP_005925,Q03111,YEATS1"
MLLT10,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 (AF10)",8028,10:21534343-21743630,1,AL,,"AF10,CCDS55708.1,ENSG00000078403.16,P55197"
MLLT11,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 11",10962,1:151057758-151068497,1,ALL,,"AF1Q,CCDS982.1,ENSG00000213190.3,NM_006818.3,NP_006809,Q13015"
MLLT3,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 (AF9)",4300,9:20341665-20622543,1,ALL,,"AF-9,AF9,CCDS6494.1,ENSG00000171843.15,NM_004529.3,NP_004520,P42568,YEATS3"
MLLT6,"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 (AF17)",4302,17:38705542-38729803,1,AL,,"AF17,CCDS11327.1,ENSG00000275023.4,FLJ23480,NM_005937.3,NP_005928,P55198"
MN1,"MN1 proto-oncogene, transcriptional regulator",4330,22:27748277-27801498,1,"AML, MDS",,"CCDS42998.1,ENSG00000169184.5,MGCR,MGCR1,MGCR1-PEN,NM_002430.2,NP_002421,Q10571"
MPL,"myeloproliferative leukaemia virus oncogene, thrombopoietin receptor",4352,1:43337849-43352772,1,MPN,MPN,"CCDS483.1,CD110,ENSG00000117400.17,NM_005373.2,NP_005364,P40238,TPOR"
MRTFA,megakaryoblastic leukemia (translocation) 1,57591,22:40411390-40533635,1,acute megakaryocytic leukaemia,,"BSAC,CCDS82720.1,ENSG00000196588.15,KIAA1438,MAL,MKL,MKL1,MRTF-A,NM_001318139.1,NP_001305068"
MSH2,mutS homolog 2 (E. coli),4436,2:47402969-47483228,1,"colorectal, endometrial, ovarian","colorectal, endometrial, ovarian","CCDS1834.1,COCA1,ENSG00000095002.14,HNPCC,HNPCC1,NM_000251.2,NP_000242,P43246"
MSH6,mutS homolog 6 (E. coli),2956,2:47783082-47810101,1,colorectal,"colorectal, endometrial, ovarian","CCDS1836.1,ENSG00000116062.14,GTBP,NM_000179.2,NP_000170,P52701"
MSI2,musashi homolog 2 (Drosophila),124540,17:57256534-57684685,1,CML,,"CCDS11596.1,ENSG00000153944.10,NM_138962.3,NP_620412,Q96DH6"
MSN,moesin,4478,X:65667670-65741931,1,ALCL,,"CCDS14382.1,ENSG00000147065.16,NM_002444.2,NP_002435,P26038"
MTCP1,mature T-cell proliferation 1,4515,X:155064034-155071226,1,T cell prolymphocytic leukaemia,,"CCDS44027.1,ENSG00000214827.9,NM_001018025.3,NP_001018025,P13MTCP1,P56278,p8MTCP1"
MTOR,mechanistic target of rapamycin,2475,1:11106535-11262507,1,"endometrial carcinoma, head and neck, clear cell renal cell carcinoma, anaplastic thyroid cancer, urothelial cell carcinoma, central nervous system tumours, testicular germ cell tumours and other tumour types",,"CCDS127.1,ENSG00000198793.12,FLJ44809,FRAP,FRAP1,FRAP2,NM_004958.3,NP_004949,P42345,RAFT1,RAPT1"
MUC1,"mucin 1, transmembrane",4582,1:155185826-155192915,1,B-NHL,,"ADMCKD,ADMCKD1,CCDS72933.1,CD227,ENSG00000185499.16,MCD,MCKD,MCKD1,NM_001204286.1,NP_001191215,PEM,PUM"
MUTYH,mutY homolog (E. coli),4595,1:45329242-45340388,1,,colorectal,"CCDS520.1,ENSG00000132781.17,MYH,NM_012222.2,NP_036354,Q9UIF7"
MYB,v-myb myeloblastosis viral oncogene homolog,4602,6:135181315-135219167,1,adenoid cystic carcinoma,,"CCDS47481.1,ENSG00000118513.18,NM_001130173.1,NP_001123645,P10242,c-myb"
MYC,v-myc myelocytomatosis viral oncogene homolog (avian),4609,8:127736069-127741434,1,"Burkitt lymphoma, amplified in other cancers, B-CLL",,"CCDS6359.2,ENSG00000136997.17,MYCC,NM_002467.4,NP_002458,NP_002458.2,bHLHe39,c-Myc"
MYCL,v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog,4610,1:39895426-39902013,1,small cell lung carcinoma,,"CCDS53300.1,ENSG00000116990.10,LMYC,MYCL1,NM_001033082.2,NP_001028254,P12524,bHLHe38"
MYCN,"v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)",4613,2:15940564-15947007,1,"neuroblastoma, Wilms tumour",,"CCDS1687.1,ENSG00000134323.11,MYCNOT,N-myc,NMYC,NM_005378.5,NP_001280157,NP_005369,NP_001280162.1,P04198,bHLHe37"
MYD88,myeloid differentiation primary response gene (88),4615,3:38138478-38143019,1,ABC-DLBCL,,"CCDS54565.1,ENSG00000172936.12,NM_001172567.1,NP_001166038"
MYH11,"myosin, heavy polypeptide 11, smooth muscle",4629,16:15703172-15857011,1,AML,,"CCDS45423.1,ENSG00000133392.17,NM_001040114.1,NP_001035203,P35749,SMHC,SMMHC"
MYH9,"myosin, heavy polypeptide 9, non-muscle",4627,22:36281277-36388067,1,ALCL,,"CCDS13927.1,DFNA17,ENSG00000100345.21,EPSTS,FTNS,MHA,NMHC-II-A,NMMHCA,NM_002473.5,NP_002464,P35579"
MYO5A,"myosin VA (heavy chain 12, myoxin)",4644,15:52307283-52529050,1,Spitzoid tumour,,"CCDS42037.1,ENSG00000197535.14,GS1,MYH12,MYO5,MYR12,NM_000259.3,NP_000250,NP_000250.3,Q9Y4I1"
MYOD1,myogenic differentiation 1,4654,11:17719568-17722131,1,embryonal rhabdomyosarcoma,,"CCDS7826.1,ENSG00000129152.3,MYF3,MYOD,NM_002478.4,NP_002469,P15172,PUM,bHLHc1"
NAB2,NGFI-A binding protein 2,4665,12:57088894-57095476,1,"solitary fibrous tumour, meningeal haemangiopericytoma",,"CCDS8930.1,ENSG00000166886.12,MADER,NM_005967.3,NP_005958,Q15742"
NBN,nibrin,4683,8:89933336-89984716,1,,"NHL, glioma, medulloblastoma, rhabdomyosarcoma","AT-V1,AT-V2,ATV,CCDS6249.1,ENSG00000104320.13,NBS,NBS1,NM_002485.4,NP_002476,O60934"
NCOA1,nuclear receptor coactivator 1,8648,2:24491932-24770702,1,alveolar rhabdomyosarcoma,,"CCDS1712.1,ENSG00000084676.15,F-SRC-1,KAT13A,NCoA-1,Q15788,RIP160,SRC1,bHLHe74"
NCOA2,nuclear receptor coactivator 2 (TIF2),10499,8:70109762-70403805,1,"AML, chondrosarcoma, rhabdomyosarcoma",,"CCDS47872.1,ENSG00000140396.12,GRIP1,KAT13C,NCoA-2,NM_006540.3,NP_001308636,NP_006531,NP_001308632,NP_001308641.1,NP_001308642.1,NP_001308640.1,Q15596,TIF2,bHLHe75"
NCOA4,nuclear receptor coactivator 4 - PTC3 (ELE1),8031,10:46006412-46030607,1,papillary thyroid,,"ARA70,CCDS73094.1,DKFZp762E1112,ELE1,ENSG00000266412.5,NM_001145260.1,NP_001138732,PTC3,Q13772,RFG"
NCOR1,nuclear receptor corepressor 1,9611,17:16029157-16215549,1,breast,,"CCDS11175.1,ENSG00000141027.20,KIAA1047,MGC104216,N-CoR,NM_006311.3,NP_006302,O75376,PPP1R109,TRAC1,hCIT529I10,hN-CoR"
NCOR2,nuclear receptor corepressor 2,9612,12:124324415-124495252,1,prostate,,"CCDS41858.2,CTG26,ENSG00000196498.13,NM_006312.5,NP_006303,SMRT,SMRTE,TNRC14,TRAC-1"
NDRG1,N-myc downstream regulated 1,10397,8:133237176-133297586,1,prostate,,"CAP43,CCDS34945.1,DRG1,ENSG00000104419.14,NDR1,NM_001135242.1,NP_001128714,Q92597,RTP,TDD5"
NF1,neurofibromatosis type 1 gene,4763,17:31094927-31377677,1,"neurofibroma, glioma","neurofibroma, glioma","CCDS42292.1,ENSG00000196712.17,NM_001042492.2,NP_001035957,P21359"
NF2,neurofibromatosis type 2 gene,4771,22:29603558-29698598,1,"meningioma, acoustic neuroma, renal","meningioma, acoustic neuroma","ACN,BANF,CCDS13861.1,ENSG00000186575.17,NM_000268.3,NP_000259,P35240,SCH,merlin"
NFATC2,"nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2",4773,20:51386957-51542719,1,Ewing sarcoma,,"CCDS13437.1,ENSG00000101096.19,NF-ATP,NFAT1,NFATp,NM_173091.3,NP_775114,NP_001245226.1,Q13469"
NFE2L2,nuclear factor (erythroid-derived 2)-like 2 (NRF2),4780,2:177230305-177265131,1,"NSCLC, HNSCC",,"CCDS42782.1,ENSG00000116044.15,NM_006164.4,NP_006155,NP_001300831.1,NP_001300832.1,NRF2,Q16236"
NFIB,nuclear factor I/B,4781,9:14087569-14313667,1,"adenoid cystic carcinoma, lipoma",,"CCDS55291.1,ENSG00000147862.16,NFI-RED,NFIB2,NFIB3,NM_001190737.1,NP_001177666,O00712"
NFKB2,nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100),4791,10:102394597-102402524,1,B-NHL,,"CCDS41564.1,ENSG00000077150.18,LYT-10,NF-kB2,NM_001322935.1,NP_001309863,NP_001070962,NP_001309864.1,Q00653,p105,p49/p100,p52"
NFKBIE,"nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon",4794,6:44258166-44265788,1,"CLL, desmoplastic melanoma",,"CCDS34463.1,ENSG00000146232.16,IKBE,NM_004556.2,NP_004547,O00221"
NIN,ninein (GSK3B interacting protein),51199,14:50725840-50831121,1,MPN,,"CCDS32079.1,ENSG00000100503.23,NM_182946.1,NP_891991,NP_891991.1,Q8N4C6"
NKX2-1,NK2 homeobox 1,7080,14:36516392-36520228,1,NSCLC,,"BCH,CCDS41945.1,ENSG00000136352.17,NKX2A,NM_001079668.2,NP_001073136,P43699,TITF1,TTF-1,TTF1"
NONO,"non-POU domain containing, octamer-binding",4841,X:71283583-71301168,1,papillary renal,,"CCDS14410.1,ENSG00000147140.15,NMT55,NM_007363.4,NP_031389,NRB54,P54,P54NRB,PPP1R114,Q15233"
NOTCH1,"Notch homolog 1, translocation-associated (Drosophila) (TAN1)",4851,9:136494433-136545786,1,"T-ALL, breast, bladder, skin SCC, lung SCC, head and neck SCC",,"CCDS43905.1,ENSG00000148400.10,NM_017617.4,NP_060087,P46531,TAN1"
NOTCH2,Notch homolog 2,4853,1:119911553-120069626,1,"marginal zone lymphoma, DLBCL, bladder",,"CCDS908.1,ENSG00000134250.19,NM_024408.3,NP_077719,NP_001186930.1,Q04721"
NPM1,"nucleophosmin (nucleolar phosphoprotein B23, numatrin)",4869,5:171387648-171411137,1,"NHL, APL, AML",,"B23,CCDS4376.1,ENSG00000181163.13,NM_002520.6,NPM,NP_002511,P06748"
NR4A3,"nuclear receptor subfamily 4, group A, member 3 (NOR1)",8013,9:99821855-99866891,1,extraskeletal myxoid chondrosarcoma,,"CCDS6742.1,CHN,CSMF,ENSG00000119508.17,MINOR,NM_173200.2,NOR1,NP_775292,Q92570"
NRAS,neuroblastoma RAS viral (v-ras) oncogene homolog,4893,1:114704469-114716894,1,"melanoma, MM, AML, thyroid",,"CCDS877.1,ENSG00000213281.4,N-ras,NM_002524.4,NP_002515,P01111"
NRG1,neuregulin 1,3084,8:32548635-32764407,1,NSCLC,,"CCDS6083.1,ENSG00000157168.18,GGF,HGL,HRG,NDF,NM_013956.4,NP_039250,NRG1-IT2,Q02297"
NSD1,nuclear receptor binding SET domain protein 1,64324,5:177133925-177300215,1,AML,,"ARA267,CCDS4412.1,ENSG00000165671.20,FLJ22263,KMT3B,NM_022455.4,NP_071900,Q96L73,STO"
NSD2,Wolf-Hirschhorn syndrome candidate 1(MMSET),7468,4:1892845-1982207,1,MM,,"CCDS33940.1,ENSG00000109685.17,KMT3G,MMSET,NM_133330.2,NP_579877,O96028,WHSC1"
NSD3,Wolf-Hirschhorn syndrome candidate 1-like 1 (NSD3),54904,8:38269697-38382272,1,AML,,"CCDS43729.1,ENSG00000147548.16,FLJ20353,KMT3F,NM_023034.1,NP_075447,Q9BZ95,WHISTLE,WHSC1L1"
NT5C2,"5'-nucleotidase, cytosolic II",22978,10:103088018-103193306,1,relapse ALL,,"CCDS7544.1,ENSG00000076685.18,GMP,NM_012229.4,NP_001127845,NP_036361,NP_001338098.1,NT5B,P49902,PNT5,SPG65,cN-II"
NTRK1,"neurotrophic tyrosine kinase, receptor, type 1",4914,1:156860894-156881642,1,"papillary thyroid, Spitzoid tumour",,"CCDS1161.1,ENSG00000198400.11,MTC,NM_002529.3,NP_002520,P04629,TRK,TRKA"
NTRK2,Neurotrophic Receptor Tyrosine Kinase 2,4915,9:84669778-85027070,1,"colorectal cancer, ganglioglioma, glioma, HNSCC, lung adenocarcinoma",,"CCDS6671.1,ENSG00000148053.15,Q16620,TRKB"
NTRK3,"neurotrophic tyrosine kinase, receptor, type 3",4916,15:87876757-88256731,1,"congenital fibrosarcoma, secretory breast",,"CCDS32322.1,ENSG00000140538.16,NM_001012338.2,NP_001012338,Q16288,TRKC"
NUMA1,nuclear mitotic apparatus protein 1,4926,11:72002864-72080687,1,APL,,"CCDS31633.1,ENSG00000137497.17,NM_006185.3,NP_006176,Q14980"
NUP214,nucleoporin 214kDa (CAN),8021,9:131125561-131234670,1,"AML, T-ALL",,"CAIN,CAN,CCDS6940.1,D9S46E,ENSG00000126883.16,N214,NM_005085.3,NP_005076,P35658"
NUP98,nucleoporin 98kDa,4928,11:3675010-3797792,1,AML,,"CCDS7746.1,ENSG00000110713.15,NM_016320.4,NP_057404,NUP96,P52948"
NUTM1,"NUT midline carcinoma, family member 1",256646,15:34343315-34357728,1,lethal midline carcinoma,,"C15orf55,CCDS61585.1,DKFZp434O192,ENSG00000184507.15,FAM22H,NM_001284292.1,NP_001271221,NP_001271221.1,NUT,Q86Y26"
NUTM2B,NUT family member 2B,729262,10:79703227-79712757,1,endometrial stromal sarcoma,,"A6NNL0,CCDS60574.1,ENSG00000188199.10,FAM22B,NM_001278495.1,NP_001265424,bA119F19.1"
NUTM2D,NUT family member 2A,728130,10:87357668-87367195,1,endometrial stromal sarcoma,,"ENSG00000214562.14,FAM22D,Q5VT03"
OLIG2,oligodendrocyte lineage transcription factor 2 (BHLHB1),10215,21:33025935-33029196,1,T-ALL,,"BHLHB1,CCDS13620.1,ENSG00000205927.4,OLIGO2,PRKCBP2,Q13516,RACK17,bHLHe19"
P2RY8,"purinergic receptor P2Y, G-protein coupled, 8",286530,X:1462572-1537107,1,"B-ALL, Down syndrome associated ALL",,"CCDS14115.1,ENSG00000182162.10,NM_178129.4,NP_835230,P2Y8,Q86VZ1"
PAFAH1B2,"platelet-activating factor acetylhydrolase, isoform Ib, beta subunit 30kDa",5049,11:117144267-117171048,1,MLCLS,,"CCDS8380.1,ENSG00000168092.13,NM_002572.3,NP_002563,NP_001296360.1,P68402"
PALB2,partner and localizer of BRCA2,79728,16:23603170-23641310,1,,"Wilms tumour, medulloblastoma, AML ,breast","CCDS32406.1,ENSG00000083093.9,FANCN,FLJ21816,NM_024675.3,NP_078951,Q86YC2"
PATZ1,zinc finger protein 278 (ZSG),23598,22:31325804-31346232,1,Ewing sarcoma,,"CCDS13894.1,ENSG00000100105.17,MAZR,NM_014323.2,NP_055138,PATZ,Q9HBE1,RIAZ,ZBTB19,ZNF278,ZSG,dJ400N23"
PAX3,paired box gene 3,5077,2:222199888-222298981,1,alveolar rhabdomyosarcoma,,"CCDS2448.1,ENSG00000135903.19,HUP2,NM_181459.3,NP_852124,P23760,WS1"
PAX5,paired box gene 5 (B-cell lineage specific activator protein),5079,9:36833275-37034185,1,"NHL, ALL, B-ALL",,"BSAP,CCDS6607.1,ENSG00000196092.12,NM_016734.2,NP_057953,Q02548"
PAX7,paired box gene 7,5081,1:18631006-18736138,1,alveolar rhabdomyosarcoma,,"CCDS186.1,ENSG00000009709.11,Hup1,NM_002584.2,NP_002575,P23759"
PAX8,paired box gene 8,7849,2:113215997-113278921,1,follicular thyroid,,"CCDS46398.1,ENSG00000125618.16,Q06710"
PBRM1,polybromo 1,55193,3:52547841-52685836,1,"clear cell renal carcinoma, breast",,"BAF180,CCDS43099.1,ENSG00000163939.18,NM_018313.4,NP_060783,PB1,Q86U86"
PBX1,pre-B-cell leukemia transcription factor 1,5087,1:164559635-164851831,1,"pre B-ALL, myoepithelioma",,"CCDS1246.1,ENSG00000185630.18,NM_002585.3,NP_002576,NP_001340059.1,P40424"
PCM1,pericentriolar material 1  (PTC4),5108,8:17922840-18027968,1,"papillary thyroid, CML, MPN",,"CCDS47812.1,ENSG00000078674.17,NM_006197.3,NP_006188,NP_006188.3,PTC4,Q15154"
PDCD1LG2,programmed cell death 1 ligand 2,80380,9:5510570-5571254,1,"PMBL, Hodgkin lymphoma",,"B7-DC,Btdc,CCDS6465.1,CD273,ENSG00000197646.7,NM_025239.3,NP_079515,PD-L2,PDL2,Q9BQ51,bA574F11.2"
PDE4DIP,phosphodiesterase 4D interacting protein (myomegalin),9659,1:148889463-149033016,1,MPN,,"CCDS72892.1,CMYA2,ENSG00000178104.19,KIAA0454,KIAA0477,MMGL,NM_001198834.3,NP_001185763,Q5VU43"
PDGFB,platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog),5155,22:39223359-39244751,1,DFSP,,"CCDS13987.1,ENSG00000100311.16,NM_002608.3,NP_002599,P01127,SIS,SSV"
PDGFRA,"platelet-derived growth factor, alpha-receptor",5156,4:54229097-54298247,1,"GIST, idiopathic hypereosinophilic syndrome, paediatric glioblastoma",GIST,"CCDS3495.1,CD140a,ENSG00000134853.11,GAS9,NM_006206.4,NP_006197,NP_001334757.1,NP_001334759.1,NP_001334758.1,P16234,PDGFR2"
PDGFRB,"platelet-derived growth factor receptor, beta polypeptide",5159,5:150113837-150155860,1,"MPN, AML, CMML, CML",,"CCDS4303.1,CD140b,ENSG00000113721.13,JTK12,NM_002609.3,NP_002600,NP_001341945.1,P09619,PDGFR,PDGFR1"
PER1,period homolog 1 (Drosophila),5187,17:8140472-8152435,1,"AML, CMML",,"CCDS11131.1,ENSG00000179094.15,NM_002616.2,NP_002607,O15534,PER,RIGUI"
PHF6,PHD finger protein 6,84295,X:134373312-134428789,1,ETP ALL,,"BFLS,BORJ,CCDS14639.1,CENP-31,ENSG00000156531.16,KIAA1823,MGC14797,NM_032458.2,NP_001015877,NP_115834,Q8IWS0"
PHOX2B,paired-like homeobox 2b,8929,4:41744082-41748970,1,neuroblastoma,neuroblastoma,"CCDS3463.1,ENSG00000109132.6,NBPhox,NM_003924.3,NP_003915,PMX2B,Phox2b,Q99453"
PICALM,phosphatidylinositol binding clathrin assembly protein (CALM),8301,11:85958814-86068929,1,"T-ALL, AML",,"CALM,CCDS8272.1,CLTH,ENSG00000073921.17,NM_007166.3,NP_009097,Q13492"
PIK3CA,"phosphoinositide-3-kinase, catalytic, alpha polypeptide",5290,3:179148523-179240093,1,"colorectal, gastric, glioblastoma, breast",,"CCDS43171.1,ENSG00000121879.4,NM_006218.3,NP_006209,P42336,PI3K"
PIK3CB,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",5291,3:138652699-138759359,1,"SCC, NSCLC",,"CCDS3104.1,ENSG00000051382.8,NM_006219.2,NP_006210,P42338,PIK3C1"
PIK3R1,"phosphoinositide-3-kinase, regulatory subunit 1 (alpha)",5295,5:68215720-68301821,1,"glioblastoma, ovarian, colorectal",,"CCDS3993.1,ENSG00000145675.14,GRB1,NM_181523.2,NP_852664,P27986,p85,p85-ALPHA"
PIM1,pim-1 oncogene,5292,6:37170203-37175426,1,NHL,,"CCDS4830.1,ENSG00000137193.13,NM_002648.3,NP_002639,NP_001230115.1,P11309,PIM"
PLAG1,pleiomorphic adenoma gene 1,5324,8:56160904-56211279,1,"salivary adenoma, lipoblastoma",,"CCDS6165.1,ENSG00000181690.7,NM_002655.2,NP_002646,Q6DJT9,ZNF912"
PLCG1,"phospholipase C, gamma 1",5335,20:41136960-41175721,1,angiosarcoma,,"CCDS13313.1,ENSG00000124181.14,NCKAP3,NM_002660.2,NP_002651,P19174,PLC-II,PLC1,PLC148,PLCgamma1"
PML,promyelocytic leukemia,5371,15:73994717-74046771,1,"APL, ALL",,"CCDS10255.1,ENSG00000140464.19,MYL,NM_033238.2,NP_150241,P29590,RNF71,TRIM19"
PMS2,PMS2 postmeiotic segregation increased 2 (S. cerevisiae),5395,7:5973239-6009125,1,,"colorectal, endometrial, ovarian, medulloblastoma, glioma","CCDS5343.1,ENSG00000122512.15,HNPCC4,H_DJ0042M02.9,MLH4,NM_001322014.1,NP_000526,NP_001308943.1,NP_001308935.1,P54278,PMSL2"
POLD1,"DNA polymerase delta 1, catalytic subunit",5424,19:50384340-50418010,1,CRC,CRC,"CCDS82381.1,CDC2,ENSG00000062822.13,POLD"
POLE,"polymerase (DNA directed), epsilon, catalytic subunit",5426,12:132623762-132687359,1,"colorectal carcinoma, endometrioid carcinoma, stomach carcinoma, skin cancer",colorectal cancer susceptibility,"CCDS9278.1,ENSG00000177084.16,NM_006231.3,NP_006222,POLE1,Q07864"
POLQ,DNA polymerase theta,10721,3:121431431-121546006,1,oral SCC,breast cancer,"CCDS33833.1,ENSG00000051341.13,NM_199420.3,NP_955452,O75417,POLH"
POT1,protection of telomeres 1,25913,7:124822386-124929981,1,CLL,,"CCDS5793.1,DKFZp586D211,ENSG00000128513.14,NM_015450.2,NP_056265,Q9NUX5,hPot1"
POU2AF1,"POU domain, class 2, associating factor 1 (OBF1)",5450,11:111352252-111379692,1,NHL,,"BOB1,CCDS31675.1,ENSG00000110777.11,NM_006235.2,NP_006226,OBF1,Q16633"
POU5F1,"POU domain, class 5, transcription factor 1",5460,6:31164337-31170693,1,sarcoma,,"CCDS34391.1,ENSG00000204531.17,MGC22487,NM_002701.5,NP_002692,OCT3,OTF3,Oct4,Q01860"
PPARG,"peroxisome proliferative activated receptor, gamma",5468,3:12351472-12434356,1,follicular thyroid,,"CCDS2609.1,ENSG00000132170.20,NM_015869.4,NP_056953,NR1C3,P37231,PPARG1,PPARG2,PPARgamma"
PPFIBP1,"PTPRF interacting protein, binding protein 1 (liprin beta 1)",8496,12:27524206-27695564,1,"Spitzoid tumour, inflammatory myofibroblastic tumour",,"CCDS55812.1,ENSG00000110841.13,L2,NM_177444.2,NP_803193,NP_803193.2,Q86W92,SGT2,hSGT2,hSgt2p"
PPM1D,"protein phosphatase, Mg2+/Mn2+ dependent 1D",8493,17:60600183-60666280,1,"glioma, ovarian cancer, breast cancer",,"CCDS11625.1,ENSG00000170836.11,NM_003620.3,NP_003611,O15297,PP2C-DELTA,Wip1"
PPP2R1A,"protein phosphatase 2, scaffolding subunit A, alpha",5518,19:52190039-52229533,1,clear cell ovarian carcinoma,,"CCDS12849.1,ENSG00000105568.17,NM_014225.5,NP_055040,P30153,PP2A-Aalpha,PP2AA,PR65A"
PPP6C,"protein phosphatase 6, catalytic subunit",5537,9:125146574-125189939,1,melanoma,,"CCDS48018.1,ENSG00000119414.11,NM_001123355.1,NP_001116827,O00743,PP6"
PRCC,papillary renal cell carcinoma (translocation-associated),5546,1:156767500-156800817,1,papillary renal,,"CCDS1157.1,ENSG00000143294.14,NM_005973.4,NP_005964,Q92733,RCCP1"
PRDM1,"PR domain containing 1, with ZNF domain",639,6:106086320-106109938,1,DLBCL,,"BLIMP1,CCDS5054.2,ENSG00000057657.15,NM_001198.3,NP_001189,O75626,PRDI-BF1"
PRDM16,PR domain containing 16,63976,1:3069211-3438621,1,"MDS, AML",,"CCDS41236.2,ENSG00000142611.16,KIAA1675,KMT8F,MEL1,MGC166915,NM_022114.3,NP_071397,PFM13,Q9HAZ2"
PREX2,"phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2",80243,8:67952118-68237030,1,"melanoma, pancreatic ductal adenocarcinoma",,"CCDS6201.1,DEP.2,DEPDC2,ENSG00000046889.18,FLJ12987,NM_024870.3,NP_079146,P-REX2,PPP1R129,Q70Z35"
PRF1,perforin 1 (pore forming protein),5551,10:70597349-70602775,1,,"various leukaemia, lymphoma","CCDS7305.1,ENSG00000180644.7,HPLH2,NM_005041.4,NP_005032,NP_001076585,P1,P14222,PFP"
PRKACA,protein kinase cAMP-activated catalytic subunit alpha,5566,19:14091688-14117744,1,"fibrolamellar hepatocellular carcinoma, cortisol secreting adrenal adenoma",,"CCDS12304.1,ENSG00000072062.13,NM_002730.3,NP_002721,NP_001291278.1,P17612,PKACa"
PRKAR1A,"protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)",5573,17:68512379-68533423,1,papillary thyroid,"myxoma, endocrine, papillary thyroid","CCDS11678.1,CNC1,ENSG00000108946.14,NM_212472.2,NP_997637,NP_002725,P10644,PRKAR1,TSE1"
PRRX1,paired related homeobox 1,5396,1:170663906-170739419,1,AML,,"CCDS1290.1,ENSG00000116132.11,NM_022716.3,NP_073207,P54821,PHOX1,PMX1"
PSIP1,PC4 and SFRS1 interacting protein 1 (LEDGF),11168,9:15464066-15511019,1,AML,,"CCDS6479.1,DFS70,ENSG00000164985.14,LEDGF,NM_033222.4,NP_001121689,NP_150091,O75475,PSIP2,p52,p75"
PTCH1,Homolog of Drosophila Patched gene,5727,9:95442980-95508661,1,"skin basal cell, medulloblastoma","skin basal cell, medulloblastoma","BCNS,CCDS6714.1,ENSG00000185920.15,NBCCS,NM_000264.3,NP_000255,PTCH,Q13635"
PTEN,phosphatase and tensin homolog gene,5728,10:87863113-87971930,1,"glioma, prostate, endometrial","harmartoma, glioma, prostate, endometrial","BZS,CCDS31238.1,ENSG00000171862.10,MHAM,MMAC1,NM_001304717.2,NP_000305,NP_001291646.2,P60484,PTEN1,TEP1"
PTK6,protein tyrosine kinase 6,5753,20:63528001-63537354,1,"renal, gastric, head and neck, ovarian, others",,"BRK,CCDS13524.1,ENSG00000101213.6,NM_005975.3,NP_005966,Q13882"
PTPN11,"protein tyrosine phosphatase, non-receptor type 11",5781,12:112419112-112504764,1,"JMML, AML, MDS",,"BPTP3,CCDS81741.1,ENSG00000179295.17,NS1,PTP2C,Q06124,SH-PTP2,SHP-2,SHP2"
PTPN13,"protein tyrosine phosphatase, non-receptor type 13",5783,4:86594315-86815171,1,"lung, NSCLC, gastric, peritoneal carcinomatosis",hepatocellular,"CCDS47093.1,ENSG00000163629.12,NM_080685.2,NP_542416,PTP-BAS,PTP-BL,PTP1E,PTPL1,Q12923"
PTPRB,"protein tyrosine phosphatase, receptor type, B",5787,12:70515866-70637440,1,angiosarcoma,,"CCDS44943.1,ENSG00000127329.15,NM_001109754.2,NP_001103224,P23467,PTPB"
PTPRC,"protein tyrosine phosphatase, receptor type, C",5788,1:198639007-198757476,1,T-ALL,,"CCDS1397.2,CD45,ENSG00000081237.19,GP180,LCA,NM_002838.4,NP_002829,P08575,T200"
PTPRK,"protein tyrosine phosphatase, receptor type, K",5796,6:127968977-128520476,1,colorectal,,"CCDS78179.1,ENSG00000152894.14,NM_001291981.1,NP_001278910,Q15262,R-PTP-kappa"
PTPRT,"protein tyrosine phosphatase, receptor type T",11122,20:42072752-43189969,1,"HNSCC, colorectal cancer, gastric cancer, lung cancer, melanoma",,"CCDS68127.1,ENSG00000196090.12,KIAA0283,NM_133170.3,NP_573400,RPTPrho"
QKI,"QKI, KH domain containing, RNA binding",9444,6:163414643-163578596,1,"angiocentric glioma, colorectal cancer",,"CCDS5285.1,ENSG00000112531.16,NM_006775.2,NP_006766,Q96PU8,QK3"
RABEP1,"rabaptin, RAB GTPase binding effector protein 1",9135,17:5282300-5385812,1,CMML,,"CCDS45592.1,ENSG00000029725.16,NM_004703.5,NP_004694,NP_001278510.1,Q15276,RAB5EP,RABPT5,neurocrescin,rabaptin-5"
RAC1,"ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)",5879,7:6374539-6402520,1,"melanoma, carcinoma",,"CCDS5349.1,ENSG00000136238.17,NM_018890.3,NP_061485,P63000,Rac-1,TC-25,p21-Rac1"
RAD21,RAD21 homolog (S. pombe),5885,8:116845935-116874866,1,"AML, endometrium, colorectal, lung",,"CCDS6321.1,ENSG00000164754.14,KIAA0078,NM_006265.2,NP_006256,O60216,SCC1,hHR21"
RAD51B,RAD51 paralog B,5890,14:67819779-68611565,1,"lipoma, uterine leiomyoma",,"CCDS81815.1,ENSG00000182185.18,NM_002877.5,NP_001308750,NP_001308744.1,NP_002868.1,NP_001308739.1,NP_001308747.1,NP_001308743.1,NP_001308738.1,NP_001308748.1,R51H2,RAD51L1,REC2,hREC2"
RAF1,v-raf-1 murine leukemia viral oncogene homolog 1,5894,3:12583601-12664226,1,"pilocytic astrocytoma, prostate",,"CCDS2612.1,CRAF,ENSG00000132155.11,NM_002880.3,NP_002871,NP_001341619.1,P04049,Raf-1,c-Raf"
RANBP2,RAN binding protein 2,5903,2:108719481-108785811,1,inflammatory myofibroblastic tumour,,"ADANE,ANE1,CCDS2079.1,ENSG00000153201.15,NM_006267.4,NP_006258,NUP358,P49792"
RAP1GDS1,"RAP1, GTP-GDP dissociation stimulator 1",5910,4:98261518-98442334,1,T-ALL,,"CCDS47105.1,ENSG00000138698.14,NM_001100426.1,NP_001093896,P52306,SmgGDS"
RARA,"retinoic acid receptor, alpha",5914,17:40309194-40356796,1,APL,,"CCDS11366.1,ENSG00000131759.17,NM_000964.3,NP_000955,NR1B1,P10276,RAR"
RB1,retinoblastoma gene,5925,13:48303726-48481890,1,"retinoblastoma, sarcoma, breast, small cell lung carcinoma","retinoblastoma, sarcoma, breast, small cell lung carcinoma","CCDS31973.1,ENSG00000139687.14,NM_000321.2,NP_000312,OSRC,P06400,PPP1R130,RB"
RBM10,RNA binding motif protein 10,8241,X:47145447-47186812,1,lung adenocarcinoma,,"CCDS75969.1,DXS8237E,ENSG00000182872.15,GPATC9,GPATCH9,KIAA0122,NM_001204468.1,NP_001191397,P98175,S1-1,ZRANB5"
RBM15,RNA binding motif protein 15,64783,1:110338506-110346677,1,acute megakaryocytic leukaemia,,"CCDS822.1,ENSG00000162775.14,OTT,OTT1,Q96T37"
RECQL4,RecQ protein-like 4,9401,8:144511291-144517826,1,,"osteosarcoma, skin basal cell, skin sqamous cell","CCDS75804.1,ENSG00000160957.12,NM_004260.3,NP_004251,NP_004251.3,O94761,RecQ4"
REL,v-rel reticuloendotheliosis viral oncogene homolog (avian),5966,2:60881521-60931610,1,Hodgkin lymphoma,,"CCDS1864.1,ENSG00000162924.14,I-Rel,NM_002908.3,NP_002899,Q04864,c-Rel"
RET,ret proto-oncogene,5979,10:43077027-43130351,1,"medullary thyroid, papillary thyroid, pheochromocytoma, NSCLC, Spitzoid tumour","medullary thyroid,  papillary thyroid, pheochromocytoma","CCDS7200.1,CDHF12,CDHR16,ENSG00000165731.18,HSCR1,MEN2A,MEN2B,MTC1,NM_020975.4,NP_066124,P07949,PTC,RET51"
RHOA,ras homolog family member A,387,3:49359145-49412202,1,"diffuse gastric, T cell lymphomas, paediatric Burkitt lymphoma",,"ARH12,ARHA,CCDS2795.1,ENSG00000067560.10,NM_001664.3,NP_001300870,NP_001655,NP_001300874.1,NP_001300873.1,P61586,RHOH12,Rho12,RhoA"
RHOH,ras homolog family member H,399,4:40196907-40246967,1,NHL,,"ARHH,CCDS3458.1,ENSG00000168421.12,Q15669,RhoH,TTF"
RMI2,RecQ mediated genome instability 2,116028,16:11345431-11351762,1,"PMBL, Hodgkin lymphoma",,"BLAP18,C16orf75,CCDS10548.1,ENSG00000175643.8,MGC24665,NM_152308.2,NP_689521,Q96E14"
RNF213,ring finger protein 213,57674,17:80260868-80398786,1,ALCL,,"ALO17,C17orf27,CCDS58606.1,ENSG00000173821.19,KIAA1554,KIAA1618,MYMY2,NET57,NM_001256071.2,NP_001243000"
RNF43,ring finger protein 43,54894,17:58353676-58417533,1,"cholangiocarcinoma, ovary, pancreas",,"CCDS11607.1,DKFZp781H0392,ENSG00000108375.12,FLJ20315,NP_001292473.1,Q68DV7,URCC"
ROS1,v-ros UR2 sarcoma virus oncogene homolog 1 (avian),6098,6:117288300-117425855,1,"glioblastoma, NSCLC, Spitzoid tumour, cholangiocarcinoma, borderline ovarian",,"CCDS5116.1,ENSG00000047936.10,MCF3,NM_002944.2,NP_002935,P08922,ROS,c-ros-1"
RPL10,ribosomal protein L10,6134,X:154398230-154402339,1,T-ALL,,"CCDS14746.1,DXS648,DXS648E,ENSG00000147403.16,FLJ23544,L10,NM_006013.4,NOV,NP_001290554,NP_006004,P27635,QM"
RPL22,ribosomal protein L22 (EAP),6146,1:6185020-6199612,1,"AML, CML",,"CCDS58.1,EAP,ENSG00000116251.9,L22,NM_000983.3,NP_000974,P35268"
RPL5,ribososomal protein L5,6125,1:92831983-92841924,1,T-ALL,,"CCDS741.1,ENSG00000122406.13,L5,PPP1R135,uL18"
RPN1,ribophorin I,6184,3:128619970-128650849,1,AML,,"CCDS3051.1,ENSG00000163902.11,NM_002950.3,NP_002941,OST1,P04843"
RSPO2,R-spondin 2,340419,8:107899317-108083648,1,colorectal,,"CCDS6307.1,ENSG00000147655.10,MGC35555,NM_178565.4,NP_848660,Q6UXX9"
RSPO3,R-spondin 3,84870,6:127118604-127197296,1,colorectal,,"CCDS5135.1,ENSG00000146374.13,FLJ14440,NM_032784.4,NP_116173,Q9BXY4,THSD2"
RUNX1,runt-related transcription factor 1  (AML1),861,21:34787801-35049344,1,"AML, pre B-ALL, T-ALL",,"AML1,AMLCR1,CBFA2,CCDS13639.1,ENSG00000159216.18,PEBP2A2,Q01196"
RUNX1T1,"runt-related transcription factor 1; translocated to, 1 (cyclin D-related)",862,8:91954967-92095654,1,AML,,"AML1T1,CBFA2T1,CCDS75766.1,CDR,ENSG00000079102.16,ETO,MTG8,NM_001198679.1,NP_001185608,ZMYND2"
SALL4,spalt like transcription factor 4,57167,20:51782331-51802520,1,"colorectal cancer, breast cancer, prostate cancer, glioblastoma, melanoma",,"CCDS13438.1,ENSG00000101115.12,NM_020436.4,NP_065169,Q9UJQ4,ZNF797,dJ1112F19.1"
SBDS,Shwachman-Bodian-Diamond syndrome protein,51119,7:66987677-66995601,1,,"AML, MDS","CCDS5537.1,CGI-97,ENSG00000126524.9,FLJ10917,NM_016038.3,NP_057122.2,Q9Y3A5,SDS,SWDS"
SDC4,syndecan 4,6385,20:45325288-45348424,1,NSCLC,,"CCDS13350.1,ENSG00000124145.6,NM_002999.3,NP_002990,P31431,SYND4,amphiglycan,ryudocan"
SDHA,"succinate dehydrogenase complex, subunit A, flavoprotein (Fp)",6389,5:218241-256700,1,"GIST, paraganglioma",paraganglioma,"CCDS3853.1,ENSG00000073578.16,FP,NM_004168.3,NP_004159,P31040,SDH2,SDHF"
SDHAF2,succinate dehydrogenase complex assembly factor 2,54949,11:61430073-61447529,1,,paraganglioma,"C11orf79,CCDS8007.1,ENSG00000167985.6,FLJ20487,NM_017841.2,NP_060311,PGL2,Q9NX18,SDH5"
SDHB,"succinate dehydrogenase complex, subunit B, iron sulfur (Ip)",6390,1:17018722-17054170,1,,"paraganglioma, pheochromocytoma","CCDS176.1,ENSG00000117118.9,NM_003000.2,NP_002991,P21912,SDH,SDH1"
SDHC,"succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa",6391,1:161314257-161375340,1,,"paraganglioma, pheochromocytoma","CCDS1230.1,CYB560,ENSG00000143252.14,NM_003001.3,NP_002992,PGL3,Q99643,cybL"
SDHD,"succinate dehydrogenase complex, subunit D, integral membrane protein",6392,11:112086773-112095794,1,,"paraganglioma, pheochromocytoma","CCDS31678.1,ENSG00000204370.10,NM_003002.3,NP_002993,O14521,PGL,PGL1,cybS"
SET,SET translocation,6418,9:128683655-128696400,1,T-ALL,,"2PP2A,CCDS48037.1,ENSG00000119335.16,IGAAD,IPP2A2,NM_001122821.1,NP_001116293,PHAPII,Q01105,TAF-I,TAF-IBETA"
SETBP1,SET binding protein 1,26040,18:44680898-45068510,1,"aCML, sAML, MDS/MPN-U, CMML, JMML",neuroepithelial tumours,"CCDS11923.2,ENSG00000152217.17,KIAA0437,NM_015559.2,NP_056374,Q9Y6X0,SEB"
SETD2,SET domain containing 2,29072,3:47016689-47163967,1,clear cell renal carcinoma,,"CCDS2749.2,ENSG00000181555.20,FLJ23184,HIF-1,HYPB,KIAA1732,KMT3A,NM_014159.6,NP_054878,NP_001336299.1,Q9BYW2"
SF3B1,"splicing factor 3b, subunit 1, 155kDa",23451,2:197389784-197435091,1,myelodysplastic syndrome,,"CCDS33356.1,ENSG00000115524.15,Hsh155,NM_012433.3,NP_036565,O75533,PRPF10,Prp10,SAP155,SF3b155"
SFPQ,splicing factor proline/glutamine rich(polypyrimidine tract binding protein associated),6421,1:35182932-35193148,1,papillary renal,,"CCDS388.1,ENSG00000116560.10,NM_005066.2,NP_005057,P23246,PPP1R140,PSF"
SFRP4,secreted frizzled related protein 4,6424,7:37905932-37916915,1,"colorectal cancer, melanoma, SCC, gastric cancer, oesophageal SCC",,"CCDS5453.1,ENSG00000106483.11,FRP-4,FRPHE,FRZB-2,NM_003014.3,NP_003005,Q6FHJ7,frpHE"
SH2B3,SH2B adaptor protein 3,10019,12:111405948-111451623,1,"MPN, sAML, erythrocytosis, B-ALL",,"CCDS9153.1,ENSG00000111252.10,IDDM20,LNK,NM_005475.2,NP_005466,Q9UQQ2"
SH3GL1,SH3-domain GRB2-like 1 (EEN),6455,19:4360370-4400547,1,AL,,"CCDS32874.1,CNSA1,EEN,ENSG00000141985.9,MGC111371,NM_003025.3,NP_003016,Q99961,SH3D2B,SH3P8"
SIX1,SIX homeobox 1,6495,14:60643415-60649462,1,Wilms tumour,,"CCDS9748.1,DFNA23,ENSG00000126778.9,Q15475"
SLC34A2,"solute carrier family 34 (sodium phosphate), member 2",10568,4:25655844-25678748,1,NSCLC,,"CCDS3435.1,ENSG00000157765.12,NAPI-3B,NM_006424.2,NP_006415,NP_006415.2,O95436"
SLC45A3,"solute carrier family 45, member 3",85414,1:205657851-205680459,1,prostate,,"CCDS1458.1,ENSG00000158715.5,IPCA-2,IPCA-6,IPCA-8,NM_033102.2,NP_149093,PCANAP2,PCANAP6,PCANAP8,Q96JT2,prostein"
SMAD2,SMAD family member 2,4087,18:47808957-47930559,1,"colorectal carcinoma, hepatocellular carcinoma",,"CCDS11934.1,ENSG00000175387.15,JV18-1,MADH2,MADR2,NM_005901.5,NP_005892,Q15796"
SMAD3,SMAD family member 3,4088,15:67065845-67195195,1,"colorectal carcinoma, oral squamous cell carcinoma",,"CCDS10222.1,ENSG00000166949.15,HsT17436,JV15-2,MADH3,NM_005902.3,NP_005893,P84022"
SMAD4,SMAD family member 4,4089,18:51030213-51085039,1,"colorectal, pancreatic, small intestine",gastrointestinal polyp,"CCDS11950.1,DPC4,ENSG00000141646.13,MADH4,NM_005359.5,NP_005350,Q13485"
SMARCA4,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4",6597,19:10960825-11062282,1,"NSCLC, SCCOHT",,"BAF190,BRG1,CCDS12253.1,ENSG00000127616.18,FLJ39786,NM_003072.3,NP_003063,P51532,SNF2,SNF2-BETA,SNF2L4,SNF2LB,SWI2,hSNF2b"
SMARCB1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1",6598,22:23786963-23834505,1,malignant rhabdoid,malignant rhabdoid,"BAF47,CCDS82699.1,ENSG00000099956.19,Ini1,NM_001317946.1,NP_001304875,PPP1R144,RDT,SNF5,SNF5L1,Sfh1p,Snr1,hSNFS"
SMARCE1,"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1",6605,17:40624962-40648864,1,,meningioma,"BAF57,CCDS11370.1,ENSG00000073584.19,NM_003079.4,NP_003070,Q969G3"
SMO,smoothened homolog (Drosophila),6608,7:129188872-129213545,1,skin basal cell,,"CCDS5811.1,ENSG00000128602.9,FZD11,NM_005631.4,NP_005622,Q99835,SMOH"
SND1,staphylococcal nuclease and tudor domain containing 1,27044,7:127652180-128092607,1,pancreas acinar carcinoma,,"CCDS34747.1,ENSG00000197157.10,NM_014390.2,NP_055205,Q7KZF4,TDRD11,p100"
SOCS1,suppressor of cytokine signaling 1,8651,16:11254417-11256200,1,"Hodgkin lymphoma, PMBL",,"CCDS10546.1,Cish1,ENSG00000185338.5,JAB,SOCS-1,SSI-1,TIP3"
SOX2,SRY (sex determining region Y)-box 2,6657,3:181711924-181714436,1,"NSCLC, oesophageal squamous carcinoma",,"CCDS3239.1,ENSG00000181449.3,NM_003106.3,NP_003097,P48431"
SPEN,spen family transcriptional repressor,23013,1:15847864-15940460,1,"SMZL, adenoid cystic carcinoma, DLBCL",,"CCDS164.1,ENSG00000065526.10,KIAA0929,MINT,NM_015001.2,NP_055816,Q96T58,RBM15C,SHARP"
SPOP,speckle type POZ protein,8405,17:49598884-49678110,1,"prostate, endometrial",prostate cancer,"BTBD32,CCDS11551.1,ENSG00000121067.17,NM_003563.3,NP_003554,NP_001007227,O43791,TEF2"
SRC,"SRC proto-oncogene, non-receptor tyrosine kinase",6714,20:37346154-37406050,1,"colorectal cancer, endometrial carcinoma",,"ASV,CCDS13294.1,ENSG00000197122.11,NP_005408.1,NP_938033.1,P12931,SRC1,c-src"
SRSF2,serine/arginine-rich splicing factor 2,6427,17:76734115-76737333,1,"MDS, CLL",,"CCDS11749.1,ENSG00000161547.16,NM_003016.4,NP_003007,PR264,Q01130,SC-35,SC35,SFRS2,SFRS2A"
SRSF3,serine/arginine-rich splicing factor 3,6428,6:36594368-36605600,1,follicular lymphoma,,"CCDS4823.1,ENSG00000112081.16,NM_003017.4,NP_003008,P84103,SFRS3,SRp20"
SS18,"synovial sarcoma translocation, chromosome 18",6760,18:26016253-26090625,1,synovial sarcoma,,"CCDS32807.1,ENSG00000141380.13,NM_001007559.2,NP_001007560,Q15532,SSXT,SYT"
SS18L1,synovial sarcoma translocation gene on chromosome 18-like 1,26039,20:62143795-62182484,1,synovial sarcoma,,"CCDS13491.1,CREST,ENSG00000184402.14,KIAA0693,NM_198935.2,NP_945173,O75177"
SSX1,"synovial sarcoma, X breakpoint 1",6756,X:48255317-48267444,1,synovial sarcoma,,"CCDS14290.1,CT5.1,ENSG00000126752.7,NM_005635.3,NP_005626,NP_001265620,Q16384"
SSX2,"synovial sarcoma, X breakpoint 2",6757,X:52696896-52707161,1,synovial sarcoma,,"CCDS14345.2,CT5.2a,ENSG00000241476.8,HD21,HOM-MEL-40,MGC119055,MGC15364,MGC3884,NM_003147.5,NP_003138,NP_001265626.1,Q16385,SSX"
SSX4,"synovial sarcoma, X breakpoint 4",6759,X:48383527-48393347,1,synovial sarcoma,,"CCDS35240.1,CT5.4,ENSG00000268009.5,NM_005636.3,NP_005627,O60224"
STAG2,stromal antigen 2,10735,X:123960519-124101498,1,"bladder carcinoma, glioblastoma, melanoma, Ewing's sarcoma, myeloid neoplasms",,"CCDS43990.1,ENSG00000101972.18,NM_001042749.2,NP_001036214,Q8N3U4,SA-2,SA2,SCC3B"
STAT3,signal transducer and activator of transcription 3 (acute-phase response factor),6774,17:42313324-42388568,1,T-cell large granular lymphocytic leukaemia,paediatric large granular lymphocytic leukaemia,"APRF,CCDS32656.1,ENSG00000168610.14,NM_139276.2,NP_003141.2,NP_644805.1,P40763"
STAT5B,signal transducer and activator of transcription 5B,6777,17:42199168-42276406,1,"large granular lymphocytic leukaemia, skin basal cell, APL",,"CCDS11423.1,ENSG00000173757.9,NM_012448.3,NP_036580,P51692"
STAT6,"signal transducer and activator of transcription 6, interleukin-4 induced",6778,12:57095408-57111433,1,"solitary fibrous tumour, meningeal haemangiopericytoma",,"CCDS8931.1,D12S1644,ENSG00000166888.11,IL-4-STAT,NM_003153.4,NP_003144,NP_001171549,P42226"
STIL,SCL/TAL1 interrupting locus,6491,1:47250142-47314140,1,T-ALL,,"CCDS41329.1,ENSG00000123473.15,MCPH7,NM_001048166.1,NP_001041631,Q15468,SIL"
STK11,serine/threonine kinase 11 gene (LKB1),6794,19:1206464-1228435,1,"NSCLC, pancreatic","jejunal hamartoma, ovarian, testicular, pancreatic","CCDS45896.1,ENSG00000118046.14,LKB1,NM_000455.4,NP_000446,PJS,Q15831"
STRN,"striatin, calmodulin binding protein",6801,2:36843640-36966472,1,"anaplastic thyroid, papillary thyroid, lung",,"CCDS1784.1,ENSG00000115808.11,NM_003162.3,NP_003153,O43815,PPP2R6A,STRN1"
SUFU,suppressor of fused homolog (Drosophila),51684,10:102503987-102633535,1,medulloblastoma,medulloblastoma,"CCDS7537.1,ENSG00000107882.11,NM_016169.3,NP_057253,PRO1280,Q9UMX1,SUFUH,SUFUXL"
SUZ12,suppressor of zeste 12 homolog (Drosophila),23512,17:31937018-32001045,1,endometrial stromal tumour,,"CCDS11270.1,CHET9,ENSG00000178691.10,JJAZ1,KIAA0160,NM_015355.3,NP_056170,Q15022"
SYK,spleen tyrosine kinase,6850,9:90801787-90898549,1,"MDS, peripheral T-cell lymphoma",,"CCDS6688.1,ENSG00000165025.14,NM_003177.6,NP_003168,P43405"
TAF15,"TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa",8148,17:35809455-35847242,1,"extraskeletal myxoid chondrosarcoma, ALL",,"CCDS32623.1,ENSG00000270647.5,NM_139215.2,NP_631961,Npl3,Q92804,RBP56,TAF2N,hTAFII68"
TAL1,T-cell acute lymphocytic leukemia 1 (SCL),6886,1:47216292-47229771,1,lymphoblastic leukaemia/biphasic,,"CCDS547.1,ENSG00000162367.11,NM_003189.5,NP_003180,NP_001277332,NP_001277334,P17542,SCL,TCL5,bHLHa17"
TAL2,T-cell acute lymphocytic leukemia 2,6887,9:105662457-105663112,1,T-ALL,,"CCDS6767.1,ENSG00000186051.6,NM_005421.2,NP_005412,Q16559,bHLHa19"
TBL1XR1,transducin (beta)-like 1 X-linked receptor 1,79718,3:177019355-177196478,1,"splenic marginal zone lymphoma, primary central nervous system lymphoma, colorectal carcinoma, gallbladder carcinoma",,"C21,CCDS46961.1,DC42,ENSG00000177565.16,FLJ12894,IRA1,NM_001321195.1,NP_001308122,NP_001308124.1,Q9BZK7,TBLR1"
TBX3,T-box 3,6926,12:114670255-114683590,1,"breast, large intestine, skin",,"CCDS9176.1,ENSG00000135111.15,NM_016569.3,NP_057653,O15119,TBX3-ISO,UMS,XHL"
TCEA1,"transcription elongation factor A (SII), 1",6917,8:53966556-54022529,1,salivary adenoma,,"CCDS47858.1,ENSG00000187735.13,GTF2S,NM_006756.3,NP_006747,P23193,SII,TCEA,TF2S,TFIIS"
TCF12,"transcription factor 12 (HTF4, helix-loop-helix transcription factors 4)",6938,15:56918623-57288514,1,extraskeletal myxoid chondrosarcoma,,"CCDS10160.1,ENSG00000140262.17,HEB,HTF4,HsT17266,NM_207037.1,NP_996920,NP_001309088,NP_996919,NP_001309081.1,Q99081,bHLHb20,p64"
TCF3,transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47),6929,19:1609290-1652329,1,pre B-ALL,,"CCDS12074.1,E2A,E47,ENSG00000071564.14,ITF1,MGC129647,MGC129648,NM_003200.3,NP_003191,NP_001338708.1,P15923,VDIR,bHLHb21,p75"
TCF7L2,transcription factor 7-like 2,6934,10:112950407-113167493,1,colorectal,,"CCDS53577.1,ENSG00000148737.16,NM_001146274.1,NP_001139746,Q9NQB0,TCF-4,TCF4"
TCL1A,T-cell leukemia/lymphoma 1A,8115,14:95709968-95714196,1,T-CLL,,"CCDS9941.1,ENSG00000100721.10,NM_021966.2,NP_068801,P56279,TCL1"
TENT5C,Terminal nucleotidyltransferase 5C,54855,1:117605934-117628372,1,MM,,"CCDS896.1,ENSG00000183508.4,FAM46C,FLJ20202,NM_017709.3,NP_060179,Q5VWP2"
TERT,telomerase reverse transcriptase,7015,5:1253167-1295047,1,"melanoma, glioblastoma, hepatocellular carcinoma, bladder, skin basal cell, skin squamous cell, mesothelioma, medulloblastoma, other tumour types",melanoma,"CCDS3861.2,ENSG00000164362.18,EST2,NM_198253.2,NP_937983,O14746,TCS1,TP2,TRT,hEST2"
TET1,tet methylcytosine dioxygenase 1,80312,10:68560656-68694482,1,AML,,"CCDS7281.1,CXXC6,ENSG00000138336.8,KIAA1676,LCX,NM_030625.2,NP_085128,Q8NFU7,bA119F7.1"
TET2,tet oncogene family member 2,54790,4:105146293-105279816,1,MDS,,"CCDS47120.1,ENSG00000168769.13,FLJ20032,KIAA1546,Q6N021"
TFE3,transcription factor binding to IGHM enhancer 3,7030,X:49028731-49043486,1,"papillary renal, alveolar soft part sarcoma, renal",,"CCDS14315.3,ENSG00000068323.16,NM_006521.5,NP_006512,NP_001269071.1,P19532,TFEA,bHLHe33"
TFEB,transcription factor EB,7942,6:41683978-41736259,1,renal cell carcinoma (childhood epithelioid),,"CCDS64425.1,ENSG00000112561.17,NM_001167827.2,NP_001161299,TCFEB,bHLHe35"
TFG,TRK-fused gene,10342,3:100709425-100748966,1,"papillary thyroid, ALCL, NSCLC, extraskeletal myxoid chondrosarcoma",,"CCDS2939.1,ENSG00000114354.13,FLJ36137,NM_006070.5,NP_001182407,NP_006061,Q92734,SPG57,TF6"
TGFBR2,transforming growth factor beta receptor II,7048,3:30606601-30694142,1,"head and neck, colorectal",colorectal,"CCDS33727.1,ENSG00000163513.17,MFS2,NM_001024847.2,NP_001020018,P37173,TBR-ii,TBRII"
TLX1,"T-cell leukemia, homeobox 1 (HOX11)",3195,10:101130505-101137789,1,T-ALL,,"CCDS7510.1,ENSG00000107807.12,HOX11,NM_005521.3,NP_005512,P31314,TCL3"
TLX3,"T-cell leukemia, homeobox 3 (HOX11L2)",30012,5:171309284-171312134,1,T-ALL,,"CCDS34288.1,ENSG00000164438.5,HOX11L2,NM_021025.3,NP_066305,O43711,RNX"
TMEM127,transmembrane protein 127,55654,2:96248516-96265994,1,,"pheochromocytoma, renal cell carcinoma","CCDS2018.1,ENSG00000135956.8,FLJ20507,FLJ22257,NM_017849.3,NP_001180233,NP_060319,O75204"
TMPRSS2,"transmembrane protease, serine 2",7113,21:41464553-41508065,1,prostate,,"CCDS54486.1,ENSG00000184012.11,NM_001135099.1,NP_001128571,O15393,PRSS10"
TNFAIP3,"tumor necrosis factor, alpha-induced protein 3",7128,6:137867188-137883311,1,"marginal zone B-cell lymphomas, Hodgkin lymphoma, PMBL",,"A20,CCDS5187.1,ENSG00000118503.14,NM_006290.3,NP_006281,NP_001257437,NP_001257436,OTUD7C,P21580"
TNFRSF14,"tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)",8764,1:2556366-2563829,1,follicular lymphoma,,"ATAR,CCDS44046.1,CD270,ENSG00000157873.17,HVEA,HVEM,LIGHTR,NM_003820.3,NP_003811,Q92956,TR2"
TNFRSF17,"tumor necrosis factor receptor superfamily, member 17",608,16:11965107-11968068,1,intestinal T-cell lymphoma,,"BCM,BCMA,CCDS10552.1,CD269,ENSG00000048462.10,NM_001192.2,NP_001183,Q02223,TNFRSF13A"
TOP1,topoisomerase (DNA) I,7150,20:41028818-41124487,1,AML*,,"CCDS13312.1,ENSG00000198900.5,NM_003286.2,NP_003277,P11387"
TP53,tumor protein p53,7157,17:7668402-7687538,1,"breast, colorectal, lung, sarcoma, adrenocortical, glioma, Spitzoid tumour, multiple other tumour types","breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types","CCDS11118.1,ENSG00000141510.16,LFS1,NM_001276761.1,NP_001119584,NP_000537,NP_001263689.1,NP_001263690.1,P04637,p53"
TP63,tumor protein p63,8626,3:189631427-189897279,1,"HNSCC, DLBCL",NSCLC,"CCDS3293.1,EEC3,ENSG00000073282.12,KET,NBP,NM_003722.4,NP_003713,NP_001316893.1,NP_001316077.1,OFC8,Q9H3D4,SHFM4,TP53CP,TP53L,TP73L,p51,p53CP,p63,p73H,p73L"
TPM3,tropomyosin 3,7170,1:154167465-154192211,1,"papillary thyroid, ALCL, NSCLC, Spitzoid tumour",,"CCDS41403.1,ENSG00000143549.19,NEM1,NM_152263.3,NP_689476,P06753,TRK"
TPM4,tropomyosin 4,7171,19:16067538-16102943,1,ALCL,,"CCDS46007.1,ENSG00000167460.15,NM_001145160.1,NP_001138632"
TPR,translocated promoter region,7175,1:186311652-186375325,1,"papillary thyroid, NSCLC",,"CCDS41446.1,ENSG00000047410.13,NM_003292.2,NP_003283,P12270"
TRA,T cell receptor alpha locus,6955,14:-,1,T-ALL,,
TRAF7,tumour necrosis factor receptor-associated factor 7,84231,16:2155765-2178129,1,meningioma,,"CCDS10461.1,DKFZp586I021,ENSG00000131653.12,MGC7807,NM_032271.2,NP_115647,Q6Q0C0,RFWD1,RNF119"
TRB,T cell receptor beta locus,6957,7:-,1,T-ALL,,
TRD,T cell receptor delta locus,6964,14:-,1,T-cell leukaemia,,
TRIM24,tripartite motif containing 24,8805,7:138460334-138589993,1,APL,,"CCDS5847.1,ENSG00000122779.17,NM_015905.2,NP_056989,O15164,RNF82,TIF1,TIF1A,Tif1a,hTIF1"
TRIM27,tripartite motif-containing 27,5987,6:28903002-28923989,1,papillary thyroid,,"CCDS4654.1,ENSG00000204713.10,NM_006510.4,NP_006501,P14373,RFP,RNF76"
TRIM33,"tripartite motif-containing 33 (PTC7,TIF1G)",51592,1:114392777-114511160,1,papillary thyroid,,"CCDS872.1,ENSG00000197323.11,FLJ11429,KIAA1113,NM_015906.3,NP_056990,PTC7,Q9UPN9,RFG7,TF1G,TIF1G,TIF1GAMMA,TIFGAMMA"
TRIP11,thyroid hormone receptor interactor 11,9321,14:91965991-92040059,1,AML,,"CCDS9899.1,CEV14,ENSG00000100815.12,GMAP-210,GMAP210,NM_004239.4,NP_004230,NP_001308780.1,Q15643,Trip230"
TRRAP,transformation/transcription domain-associated protein,8295,7:98878490-99013243,1,melanoma,,"CCDS59066.1,ENSG00000196367.13,NM_001244580.1,NP_001231509,PAF400,Q9Y4A5,TR-AP,Tra1"
TSC1,tuberous sclerosis 1 gene,7248,9:132891348-132944633,1,"renal cell carcinoma, bladder carcinoma","hamartoma, renal cell carcinoma, tuberous sclerosis tuber","CCDS6956.1,ENSG00000165699.14,KIAA0243,LAM,NM_000368.4,NP_000359,Q92574,TSC,hamartin"
TSC2,tuberous sclerosis 2 gene,7249,16:2047465-2088720,1,"pulmonary lymphangioleiomyomatosis (LAM), renal angiomyolipoma, HNSCC","hamartoma, renal cell carcinoma, tuberous sclerosis tuber","CCDS10458.1,ENSG00000103197.17,LAM,NM_000548.4,NP_000539,P49815,PPP1R160,TSC4,tuberin"
TSHR,thyroid stimulating hormone receptor,7253,14:80955043-81146302,1,toxic thyroid adenoma,thyroid adenoma,"CCDS9872.1,ENSG00000165409.17,LGR3"
U2AF1,U2 small nuclear RNA auxiliary factor 1,7307,21:43092956-43107587,1,"CLL, MDS",,"CCDS13694.1,ENSG00000160201.11,NM_006758.2,NP_006749,Q01081,RN,RNU2AF1,U2AF35,U2AFBP"
UBR5,ubiquitin protein ligase E3 component n-recognin 5,51366,8:102253012-102412841,1,"mantle cell lymphoma, gastric, colorectal",,"CCDS34933.1,DD5,EDD,EDD1,ENSG00000104517.12,HYD,KIAA0896,NM_015902.5,NP_056986,O95071"
USP6,ubiquitin specific peptidase 6 (Tre-2 oncogene),9098,17:5116438-5174991,1,aneurysmal bone cyst,,"CCDS11069.2,ENSG00000129204.16,HRP1,NM_001304284.1,NP_001291213,P35125,TRE17,TRESMCR,Tre-2,Tre2"
USP8,ubiquitin specific peptidase 8,9101,15:50424382-50514419,1,corticotroph adenoma,,"CCDS10137.1,ENSG00000138592.13,HumORF8,KIAA0055,NM_001128610.2,NP_001122082,P40818,SPG59,UBPY"
VHL,von Hippel-Lindau syndrome gene,7428,3:10141008-10152220,1,"renal, haemangioma, pheochromocytoma","renal, haemangioma, pheochromocytoma","CCDS2597.1,ENSG00000134086.7,NM_000551.3,NP_000542,P40337,VHL1"
WAS,Wiskott-Aldrich syndrome,7454,X:48683779-48691427,1,,lymphoma,"CCDS14303.1,ENSG00000015285.10,IMD2,NM_000377.2,NP_000368,P42768,THC,WASP,WASPA"
WDCP,chromosome 2 open reading frame 44,80304,2:24029340-24047353,1,colorectal,,"C2orf44,CCDS1705.1,ENSG00000163026.11,FLJ21945,MMAP,NM_025203.2,NP_079479,Q9H6R7"
WIF1,WNT inhibitory factor 1,11197,12:65050626-65121566,1,pleomorphic salivary gland adenoma,,"CCDS8971.1,ENSG00000156076.9,NM_007191.4,NP_009122,Q9Y5W5"
WRN,Werner syndrome (RECQL2),7486,8:31033801-31173769,1,,"osteosarcoma, meningioma, other tumour types","CCDS6082.1,ENSG00000165392.9,NM_000553.4,NP_000544,Q14191,RECQ3,RECQL2"
WT1,Wilms tumour 1 gene,7490,11:32387775-32435630,1,"Wilms tumour, desmoplastic small round cell tumour",Wilms tumour,"AWT1,CCDS7878.2,ENSG00000184937.13,GUD,NM_024426.4,NPHS4,NP_077744,NP_077744.4,WAGR,WIT-2"
WWTR1,WW domain containing transcription regulator 1,25937,3:149517235-149703273,1,epithelioid haemangioendothelioma,,"CCDS3144.1,DKFZp586I1419,ENSG00000018408.14,NM_001348362.1,NP_001161750,NP_001335291.1,Q9GZV5,TAZ"
XPA,"xeroderma pigmentosum, complementation group A",7507,9:97674909-97697357,1,,"skin basal cell, skin squamous cell, melanoma","CCDS6729.1,ENSG00000136936.10,NM_000380.3,NP_000371,P23025,XP1,XPAC"
XPC,"xeroderma pigmentosum, complementation group C",7508,3:14145147-14178783,1,,"skin basal cell, skin squamous cell, melanoma","CCDS46763.1,ENSG00000154767.14,NM_004628.4,NP_004619,NP_001341658.1,Q01831,RAD4,XPCC"
XPO1,"exportin 1 (CRM1 homolog, yeast)",7514,2:61477849-61538283,1,CLL,,"CCDS33205.1,CRM1,ENSG00000082898.16,NM_003400.3,NP_003391,O14980,emb"
YWHAE,"tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide (14-3-3 epsilon)",7531,17:1344272-1400378,1,endometrial stromal sarcoma,,"CCDS11001.1,ENSG00000108953.16,FLJ45465,NM_006761.4,NP_006752,P62258"
ZBTB16,zinc finger and BTB domain containing 16,7704,11:114059593-114250676,1,APL,,"CCDS8367.1,ENSG00000109906.13,NM_006006.4,NP_005997,NP_001341679.1,NP_001341680.1,PLZF,Q05516,ZNF145"
ZFHX3,zinc finger homeobox 3,463,16:72782885-73891871,1,"endometrial, gastric, prostate",,"ATBF1,CCDS10908.1,ENSG00000140836.16,Q15911,ZNF927"
ZMYM2,zinc finger protein 198,7750,13:19958670-20091829,1,"MPN, NHL",,"CCDS45016.1,ENSG00000121741.16,FIM,MYM,NM_197968.3,NP_001177894,NP_932072,NP_001340092.1,NP_001340090.1,NP_001340086.1,NP_001340088.1,NP_001340093.1,Q9UBW7,RAMP,ZNF198"
ZNF331,zinc finger protein 331,55422,19:53521024-53580269,1,follicular thyroid adenoma,,"CCDS33102.1,ENSG00000130844.16,NM_018555.5,NP_061025,NP_001304049,Q9NQX6,RITA,ZNF361,ZNF463"
ZNF384,zinc finger protein 384 (CIZ/NMP4),171017,12:6666648-6689510,1,ALL,,"CAGH1A,CCDS44817.1,CIZ,ENSG00000126746.17,NMP4,NM_001135734.2,NP,NP_001129206,Q8TF68,TNRC1"
ZNF521,zinc finger protein 521,25925,18:25061926-25352152,1,ALL,,"CCDS32806.1,EHZF,ENSG00000198795.10,Evi3,NM_015461.2,NP_056276,Q96K83"
ZRSR2,"zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2",8233,X:15790472-15823260,1,"MDS, CLL",,"CCDS14172.1,ENSG00000169249.12,NM_005089.3,NP_005080,Q15696,U2AF1-RS2,U2AF1L2,URP,ZC3H22"
